RESEARCH ARTICLE research R RE RES RESE BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 1 1 0 0 0 0 0 0 0 no 0 10 1 1 0 0 1
◥ ◥ ◥ ◥ ◥ ◥ ◥ BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 0 0 no 0 10 1 1 0 0 1
CORONAVIRUS CORONAVIRUS coronavirus C CO COR CORO BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 no 0 10 1 1 0 0 1
Afucosylated IgG afucosylated A Af Afu Afuc BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 no 0 9 1 0 0 0 1
responses and responses r re res resp BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 - 1 10 1 0 0 0 1
Mads Delbo mads M Ma Mad Mads BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 *,.*,.*,.,, 11 8 0 0 0 0 1
Willianne Hoepel, willianne W Wi Wil Will BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 ,-,,,,, 7 10 0 0 0 0 1
Steven W. steven S St Ste Stev BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 0 0 .,..,,..,, 10 10 0 0 0 0 1
Neeltje A. neeltje N Ne Nee Neel BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 .,..,,.., 9 9 0 0 0 0 1
Gertjan Wolbink, gertjan G Ge Ger Gert BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 ,,.,.,, 7 8 0 0 0 0 1
Alexander P. alexander A Al Ale Alex BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 0 0 ..,-,, 6 8 0 0 0 0 1
Jeroen den jeroen J Je Jer Jero BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 ,.,,., 6 9 0 0 0 0 1
INTRODUCTION: Antibody introduction: I IN INT INTR BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 0 1 :- 2 9 0 0 0 0 1
sidered static sidered s si sid side BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 no 0 9 0 0 0 0 1
and subclass. and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 .- 2 8 0 0 0 0 1
at position at a at at at BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 - 1 8 0 0 0 0 1
globulin G globulin g gl glo glob BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 ()' 3 9 0 0 0 0 1
effector functions. effector e ef eff effe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 ., 2 9 0 0 0 0 1
highly variable highly h hi hig high BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 ,- 2 9 0 0 0 0 1
pecially for pecially p pe pec peci BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 . 1 10 0 0 0 0 1
core fucosylation core c co cor core BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 () 2 8 0 0 0 0 1
increased antibody-dependent increased i in inc incr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 -- 2 8 0 0 0 0 1
toxicity (ADCC) toxicity t to tox toxi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 ()- 3 9 0 0 0 0 1
Fc receptor fc F Fc Fc Fc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 1 (). 3 9 0 0 0 0 1
constant levels constant c co con cons BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 -- 2 9 0 0 0 0 1
lation above lation l la lat lati BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 , 1 9 0 0 0 0 1
low core low l lo low low BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 3 no 0 9 0 0 0 0 1
reported. These reported. r re rep repo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 .- 2 10 0 0 0 0 1
gens on gens g ge gen gens BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 3 no 0 9 0 0 0 0 1
and dengue and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 .,- 3 9 0 0 0 0 1
tigated the tigated t ti tig tiga BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 3 no 0 9 0 0 0 0 1
various antigens various v va var vari BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 no 0 9 0 0 0 0 1
and proinflammatory and a an and and BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 -. 2 9 0 0 0 0 1
RATIONALE: Afucosylated rationale: R RA RAT RATI BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 0 3 : 1 9 0 0 0 0 1
only been only o on onl only BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 - 1 9 0 0 0 0 1
sponses against sponses s sp spo spon BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 3 no 0 9 0 0 0 0 1
two enveloped two t tw two two BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 ., 2 9 0 0 0 0 1
the hypothesis the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 -, 2 10 0 0 0 0 1
membrane-embedded proteins membrane-embedded m me mem memb BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 -- 2 8 0 0 0 0 1
cific B cific c ci cif cifi BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 4 no 0 10 1 0 0 0 1
IgG. We igg. I Ig IgG IgG. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 4 .- 2 8 1 0 0 0 1
ural infections ural u ur ura ural BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 4 - 1 8 1 0 0 0 1
enveloped viruses, enveloped e en env enve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 ,, 2 9 1 0 0 0 1
and live and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 . 1 9 1 0 0 0 1
assessed the assessed a as ass asse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 no 0 9 1 0 0 0 1
such a such s su suc such BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 -. 2 5 1 0 0 0 1
RESULTS: Analogous results: R RE RES RESU BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 0 4 :, 2 9 1 0 0 0 1
the response the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 no 0 9 1 0 0 0 1
clear signatures clear c cl cle clea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 - 1 10 1 0 0 0 1
specific IgG. specific s sp spe spec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 .,- 3 9 1 0 0 0 1
enveloped virus, enveloped e en env enve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 ,, 2 9 1 0 0 0 1
fucosylated. The fucosylated. f fu fuc fuco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 4 .- 2 9 1 0 0 0 1
sponses varied, sponses s sp spo spon BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 4 , 1 9 1 0 0 0 1
between antigens. between b be bet betw BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 .- 2 9 1 0 0 0 1
tial to tial t ti tia tial BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 4 - 1 9 1 0 0 0 1
tion did tion t ti tio tion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 4 no 0 9 1 0 0 0 1
against hepatitis against a ag aga agai BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 ., 2 10 1 0 0 0 1
IgG responses igg I Ig IgG IgG BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 4 - 1 9 1 0 0 0 1
uated viruses. uated u ua uat uate BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 4 . 1 10 1 0 0 0 1
coronavirus 2 coronavirus c co cor coro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 4 (--)- 5 10 1 0 0 0 1
IgG were igg I Ig IgG IgG BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 4 - 1 9 1 0 0 0 1
patients but patients p pa pat pati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 - 1 9 1 0 0 0 1
toms. Over toms. t to tom toms BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 4 ., 2 10 1 0 0 0 1
amount of amount a am amo amou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 --- 3 8 1 0 0 0 1
increased markedly, increased i in inc incr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 , 1 9 1 0 0 0 1
levels similar levels l le lev leve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 . 1 8 1 0 0 0 1
Afucosylated IgG afucosylated A Af Afu Afuc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 4 -(-) 4 9 1 0 0 0 1
release in release r re rel rele BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 , 1 9 1 0 0 0 1
is in is i is is is BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 - 1 9 1 0 0 0 1
CoV-2-specific IgG cov-2-specific C Co CoV CoV- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 4 --- 3 9 1 0 0 0 1
C-reactive protein c-reactive C C- C-r C-re BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 4 -(). 4 8 1 0 0 0 1
CONCLUSION: This conclusion: C CO CON CONC BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 0 7 :- 2 8 1 0 0 0 1
ing foreign ing i in ing ing BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 0 7 no 0 10 1 0 0 0 1
cells may cells c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 no 0 9 1 0 0 0 1
IgG immune igg I Ig IgG IgG BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 7 .- 2 8 1 0 0 0 1
sponse is sponse s sp spo spon BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 7 no 0 9 1 0 0 0 1
and between and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 . 1 8 1 0 0 0 1
response is response r re res resp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 , 1 8 1 0 0 0 1
for the for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 - 1 9 1 0 0 0 1
expressing natural expressing e ex exp expr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 () 2 8 1 0 0 0 1
cells. This cells. c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 .-- 3 9 1 0 0 0 1
ample, against ample, a am amp ampl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 ,- 2 8 1 0 0 0 1
vaccines by vaccines v va vac vacc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 no 0 9 1 0 0 0 1
protein, as protein, p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 , 1 9 1 0 0 0 1
vaccines or vaccines v va vac vacc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 .,- 3 8 1 0 0 0 1
CoV-2, this cov-2, C Co CoV CoV- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 7 -, 2 8 1 0 0 0 1
promote the promote p pr pro prom BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 - 1 8 1 0 0 0 1
conditions with conditions c co con cond BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 no 0 9 1 0 0 0 1
seroconversion. ▪ seroconversion. s se ser sero BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 8 . 1 10 1 0 0 0 1
RESEARCH RESEARCH research R RE RES RESE BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 1 1 0 0 0 0 0 0 8 no 0 10 1 1 0 0 0
Larsen et larsen L La Lar Lars BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 0 8 .,,() 5 10 1 1 0 0 0
26 February 26 2 26 26 26 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 0 8 no 0 4 1 1 0 0 0
1 of 1 1 1 1 1 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 8 no 0 10 1 1 0 0 0
The list the T Th The The BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 8 . 1 10 1 0 0 0 1
*These authors *these * *T *Th *The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 8 *. 2 6 1 0 0 0 1
†Corresponding author. †corresponding † †C †Co †Cor BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 8 .:.@. 5 7 1 0 0 0 1
This is this T Th Thi This BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 8 - 1 6 1 0 0 0 1
the terms the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 no 0 7 1 0 0 0 1
(https://creativecommons.org/licenses/by/4.0/), which (https://creativecommons.org/licenses/by/4.0/), ( (h (ht (htt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 1 0 8 (://.///./), 12 7 1 0 0 0 1
permits unrestricted permits p pe per perm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 ,, 2 8 1 0 0 0 1
any medium, any a an any any BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 ,. 2 7 1 0 0 0 1
Cite this cite C Ci Cit Cite BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 8 ...,, 5 7 1 0 0 0 1
eabc8378 (2021). eabc8378 e ea eab eabc BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 8 ().:./. 7 6 1 0 0 0 1
READ THE read R RE REA READ BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 1 1 0 0 0 0 0 0 10 no 0 6 1 1 0 0 1
https://doi.org/10.1126/science.abc8378 https://doi.org/10.1126/science.abc8378 https://doi.org/10.1126/science.abc8378 h ht htt http BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 0 10 ://././. 8 10 1 1 0 0 1
Self Self self S Se Sel Self BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 10 no 0 10 1 0 0 0 1
• Non-enveloped • • • • • BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 0 10 •- 2 9 0 0 0 0 1
• Protein • • • • • BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 0 10 • 1 10 0 0 0 0 1
• Alloantigen • • • • • BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 0 10 • 1 8 0 0 0 0 1
• Enveloped • • • • • BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 0 10 • 1 10 0 0 0 0 1
Alloantigen Alloantigen alloantigen A Al All Allo BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 10 no 0 10 1 0 0 0 1
Enveloped viral enveloped E En Env Enve BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 10 no 0 10 0 0 0 0 1
Foreign antigen foreign F Fo For Fore BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 10 no 0 10 1 0 0 0 1
IgG IgG igg I Ig IgG IgG BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 10 no 0 10 1 0 0 0 1
FcγRIII FcγRIII fcγriii F Fc Fcγ FcγR BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 10 no 0 5 1 0 0 0 1
FcγR-stimulus FcγR-stimulus fcγr-stimulus F Fc Fcγ FcγR BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 10 - 1 10 1 0 0 0 1
TLR3-stimulus TLR3-stimulus tlr3-stimulus T TL TLR TLR3 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 10 - 1 10 1 0 0 0 1
Soluble antigen soluble S So Sol Solu BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 10 no 0 5 0 0 0 0 1
Membrane bound membrane M Me Mem Memb BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 10 no 0 10 0 0 0 0 1
Acute phase acute A Ac Acu Acut BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 10 / 1 10 1 0 0 0 1
Afucosylated IgG afucosylated A Af Afu Afuc BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 10 no 0 10 1 0 0 0 1
FcγRIII FcγRIII fcγriii F Fc Fcγ FcγR BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 10 no 0 7 1 0 0 0 1
activation activation activation a ac act acti BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 10 no 0 10 1 0 0 0 1
Myeloid and myeloid M My Mye Myel BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 10 no 0 6 1 0 0 0 1
(ADCC/Phagocytosis/IL-6 secretion) (adcc/phagocytosis/il-6 ( (A (AD (ADC BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 10 (//-) 5 10 1 0 0 0 1
Fucosylated IgG fucosylated F Fu Fuc Fuco BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 11 no 0 10 1 0 0 0 1
Afucosylated IgG afucosylated A Af Afu Afuc BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 11 -. 2 9 1 1 0 0 1
Only membrane only O On Onl Only BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 11 no 0 9 1 1 0 0 1
of other of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 11 ,. 2 10 1 1 0 0 1
afucosylated IgG afucosylated a af afu afuc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 11 ,--, 4 9 1 1 0 0 1
during a during d du dur duri BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 11 . 1 2 1 1 0 0 1
RESEARCH ARTICLE research R RE RES RESE BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 1 1 0 0 0 0 0 1 0 no 0 10 1 1 0 0 1
◥ ◥ ◥ ◥ ◥ ◥ ◥ BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 0 no 0 10 1 1 0 0 1
CORONAVIRUS CORONAVIRUS coronavirus C CO COR CORO BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 no 0 10 1 1 0 0 1
Afucosylated IgG afucosylated A Af Afu Afuc BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 no 0 9 1 0 0 0 1
responses and responses r re res resp BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 - 1 10 1 0 0 0 1
Mads Delbo mads M Ma Mad Mads BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 ,*,.,*,.,*,.,, 14 10 0 0 0 0 1
Willianne Hoepel willianne W Wi Wil Will BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 ,,-,,,,,,,, 11 10 0 0 0 0 1
Tonći Šuštić tonći T To Ton Tonć BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 ,,.,,..,,, 10 8 0 0 0 0 1
Carolien A. carolien C Ca Car Caro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 ..,,.,.., 9 8 0 0 0 0 1
Chiara Elisabeth chiara C Ch Chi Chia BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 ,,..,,,,, 9 9 0 0 0 0 1
Rogier W. rogier R Ro Rog Rogi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 .,,.,,.., 9 8 0 0 0 0 1
Amsterdam UMC amsterdam A Am Ams Amst BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 -,,,,, 6 8 0 0 0 0 1
Hans L. hans H Ha Han Hans BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 1 0 .,,.,,, 7 8 0 0 0 0 1
Immunoglobulin G immunoglobulin I Im Imm Immu BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 1 (). 3 9 0 0 0 0 1
conserved N-linked conserved c co con cons BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 1 --,, 4 9 0 0 0 0 1
composition in composition c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 1 . 1 10 0 0 0 0 1
for their for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 1 ()., 4 9 0 0 0 0 1
(approximately 6% (approximately ( (a (ap (app BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 1 () 2 9 0 0 0 0 1
generally not generally g ge gen gene BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 1 . 1 9 0 0 0 0 1
brewing cytokine brewing b br bre brew BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 1 -.-, 4 9 0 0 0 0 1
those with those t th tho thos BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 1 , 1 9 0 0 0 0 1
respiratory syndrome respiratory r re res resp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 1 (--), 5 9 0 0 0 0 1
acute phase acute a ac acu acut BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 1 ., 2 9 0 0 0 0 1
enveloped viruses, enveloped e en env enve BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 1 ,-. 3 3 0 0 0 0 1
A A a A A A A BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 1 3 no 0 10 0 0 0 0 1
ntibody function ntibody n nt nti ntib BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 3 - 1 6 1 0 0 0 1
sidered static sidered s si sid side BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 3 no 0 7 1 0 0 0 1
their isotype their t th the thei BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 3 . 1 8 1 0 0 0 1
of a of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 3 -- 2 7 1 0 0 0 1
tion 297 tion t ti tio tion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 3 - 1 7 1 0 0 0 1
globulin G globulin g gl glo glob BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 3 () 2 9 1 0 0 0 1
functions (1-3). functions f fu fun func BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 3 (-)., 5 8 1 0 0 0 1
of this of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 3 , 1 8 1 0 0 0 1
functional consequences functional f fu fun func BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 3 (-).- 5 8 1 0 0 0 1
cially true cially c ci cia cial BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 3 no 0 9 1 0 0 0 1
Fc glycan. fc F Fc Fc Fc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 3 .- 2 9 1 0 0 0 1
out core out o ou out out BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 3 - 1 9 1 0 0 0 1
dependent cellular dependent d de dep depe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 3 (), 3 9 1 0 0 0 1
increased IgG-Fc increased i in inc incr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 3 -() 3 10 1 0 0 0 1
(5, 6), (5, ( (5 (5, (5, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 3 (,),-- 6 9 1 0 0 0 1
engineered monoclonal engineered e en eng engi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 3 () 2 8 1 0 0 0 1
lack core lack l la lac lack BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 3 (). 3 9 1 0 0 0 1
Generally, changes generally, G Ge Gen Gene BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 3 , 1 8 1 0 0 0 1
associated with associated a as ass asso BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 3 ,, 2 8 1 0 0 0 1
diseases and diseases d di dis dise BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 3 - 1 8 1 0 0 0 1
galactosylation, which galactosylation, g ga gal gala BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 3 , 1 9 1 0 0 0 1
advancing age. advancing a ad adv adva BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 3 . 1 8 1 0 0 0 1
young women, young y yo you youn BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 1 3 ,- 2 9 1 0 0 0 1
during menopause during d du dur duri BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 3 no 0 8 1 0 0 0 1
(8). IgG-Fc (8). ( (8 (8) (8). BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 4 ().-,- 6 9 1 0 0 0 1
ing slightly ing i in ing ing BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 1 4 no 0 9 1 0 0 0 1
(9), after (9), ( (9 (9) (9), BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 4 (),, 4 9 1 0 0 0 1
albeit with albeit a al alb albe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 4 no 0 8 1 0 0 0 1
life (8, life l li lif life BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 (,). 4 2 1 0 0 0 1
Despite the despite D De Des Desp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 4 no 0 8 1 0 0 0 1
fucosylation during fucosylation f fu fuc fuco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 4 , 1 9 1 0 0 0 1
against red against a ag aga agai BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 () 2 9 1 0 0 0 1
show low show s sh sho show BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 -, 2 9 1 0 0 0 1
even down even e ev eve even BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 (-). 4 9 1 0 0 0 1
contrast, overall contrast, c co con cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 ,- 2 9 1 0 0 0 1
consistently high. consistently c co con cons BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 .,- 3 8 1 0 0 0 1
fucosylation is fucosylation f fu fuc fuco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 4 - 1 9 1 0 0 0 1
mine disease mine m mi min mine BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 - 1 9 1 0 0 0 1
alloimmunizations, resulting alloimmunizations, a al all allo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 4 ,- 2 9 1 0 0 0 1
bocytopenia and bocytopenia b bo boc bocy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 4 no 0 9 1 0 0 0 1
by afucosylated by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 (-). 4 9 1 0 0 0 1
to the to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 no 0 10 1 0 0 0 1
platelets and platelets p pl pla plat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 4 , 1 9 1 0 0 0 1
only been only o on onl only BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 - 1 8 1 0 0 0 1
deficiency virus deficiency d de def defi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 ()(,). 6 10 1 0 0 0 1
Low core low L Lo Low Low BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 1 4 - 1 9 1 0 0 0 1
has been has h ha has has BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 no 0 8 1 0 0 0 1
controllers of controllers c co con cont BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 ,, 2 9 1 0 0 0 1
it has it i it it it BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 - 1 9 1 0 0 0 1
ogy owing ogy o og ogy ogy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 6 no 0 8 1 0 0 0 1
(15, 16). (15, ( (1 (15 (15, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 6 (,). 4 8 1 0 0 0 1
core fucosylation core c co cor core BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 ,. 2 8 1 0 0 0 1
Similar afucosylated similar S Si Sim Simi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 6 - 1 8 1 0 0 0 1
ious alloimmune ious i io iou ious BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 6 (-,), 5 8 1 0 0 0 1
(16), and (16), ( (1 (16 (16) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 6 (),(), 6 9 1 0 0 0 1
against surface-exposed, against a ag aga agai BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 -,- 3 8 1 0 0 0 1
proteins. Therefore, proteins. p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 .,- 3 9 1 0 0 0 1
ation in ation a at ati atio BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 6 no 0 9 1 0 0 0 1
natural infections natural n na nat natu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 ,- 2 10 1 0 0 0 1
ing HIV, ing i in ing ing BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 1 6 ,(),, 5 9 1 0 0 0 1
mumps virus, mumps m mu mum mump BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 ,(), 4 8 1 0 0 0 1
severe acute severe s se sev seve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 no 0 9 1 0 0 0 1
2 (SARS-CoV-2). 2 2 2 2 2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 1 6 (--). 5 9 1 0 0 0 1
a nonenveloped a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 1 6 (),- 4 9 1 0 0 0 1
nation with nation n na nat nati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 1 6 -, 2 9 1 0 0 0 1
attenuated enveloped attenuated a at att atte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 no 0 9 1 0 0 0 1
the antigen the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 - 1 8 1 0 0 0 1
minant for minant m mi min mina BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 6 -. 2 6 1 0 0 0 1
Afucosylated IgG afucosylated A Af Afu Afuc BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 7 no 0 10 0 0 0 0 1
enveloped viruses enveloped e en env enve BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 7 no 0 5 0 0 0 0 1
IgG-Fc glycosylation igg-fc I Ig IgG IgG- BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 7 -- 2 9 1 0 0 0 1
and antigen-specific and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 7 -- 2 9 1 0 0 0 1
sible with sible s si sib sibl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 7 - 1 8 1 0 0 0 1
mass spectrometry mass m ma mas mass BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 7 (-)(..) 7 9 1 0 0 0 1
(12, 17, (12, ( (1 (12 (12, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 7 (,,).- 6 10 1 0 0 0 1
antibodies against antibodies a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 7 no 0 8 1 0 0 0 1
platelet antigen platelet p pl pla plat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 7 (-) 3 9 1 0 0 0 1
reduced (Fig. reduced r re red redu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 7 (.)(),- 7 9 1 0 0 0 1
vious findings vious v vi vio viou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 7 (,). 4 9 1 0 0 0 1
Analogous to analogous A An Ana Anal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 7 no 0 8 1 0 0 0 1
(11-13, 17), (11-13, ( (1 (11 (11- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 7 (-,),- 6 9 1 0 0 0 1
ruses CMV ruses r ru rus ruse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 7 no 0 8 1 0 0 0 1
afucosylation of afucosylation a af afu afuc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 7 -(. 3 9 1 0 0 0 1
2B). By 2b). 2 2B 2B) 2B). BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 7 )., 3 9 1 0 0 0 1
virus parvovirus virus v vi vir viru BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 7 (.). 4 9 1 0 0 0 1
The total the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 7 no 0 9 1 0 0 0 1
throughout (Fig. throughout t th thr thro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 7 (.,),- 6 9 1 0 0 0 1
vious findings vious v vi vio viou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 7 - 1 8 1 0 0 0 1
sponses result sponses s sp spo spon BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 7 (,,). 5 9 1 0 0 0 1
The extent the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 7 no 0 9 1 0 0 0 1
enveloped viruses enveloped e en env enve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 7 , 1 8 1 0 0 0 1
between individuals between b be bet betw BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 7 no 0 8 1 0 0 0 1
of antigen, of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 7 , 1 9 1 0 0 0 1
immune responses immune i im imm immu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 7 - 1 8 1 0 0 0 1
gens (17). gens g ge gen gens BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 7 (). 3 9 1 0 0 0 1
for CMV for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 7 (.), 4 9 1 0 0 0 1
confirming previous confirming c co con conf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 7 (). 3 9 1 0 0 0 1
Afucosylated IgG afucosylated A Af Afu Afuc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 7 - 1 8 1 0 0 0 1
panied by panied p pa pan pani BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 7 (.). 4 9 1 0 0 0 1
To test to T To To To BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 7 no 0 7 1 0 0 0 1
greater intrinsic greater g gr gre grea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 7 - 1 9 1 0 0 0 1
sylated IgG sylated s sy syl syla BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 7 , 1 9 1 0 0 0 1
RESEARCH RESEARCH research R RE RES RESE BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 1 1 0 0 0 0 0 2 9 no 0 10 1 1 0 0 0
Larsen et larsen L La Lar Lars BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 2 9 .,,() 5 10 1 1 0 0 0
26 February 26 2 26 26 26 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 9 no 0 3 1 1 0 0 0
1 of 1 1 1 1 1 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 2 9 no 0 10 1 1 0 0 0
1 Department 1 1 1 1 1 BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 2 9 ,,,.,,,,. 9 9 1 0 0 0 1
Proteomics and proteomics P Pr Pro Prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 9 ,,,.,, 6 9 1 0 0 0 1
Immunology Center, immunology I Im Imm Immu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 9 ,,.,,,,., 9 9 1 0 0 0 1
Experimental Vascular experimental E Ex Exp Expe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 9 ,,,,.,, 7 9 1 0 0 0 1
Amsterdam, Amsterdam, amsterdam, A Am Ams Amst BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 9 ,,.,,.,,, 9 10 1 0 0 0 1
of Amsterdam, of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 9 ,,.,,,.,,, 10 9 1 0 0 0 1
Amsterdam, Netherlands. amsterdam, A Am Ams Amst BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 9 ,.,,,.,,,. 10 10 1 0 0 0 1
Medicine, Amsterdam medicine, M Me Med Medi BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 9 ,(),,,.-,,,. 12 8 1 0 0 0 1
*These authors *these * *T *Th *The BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 11 *.-. 4 10 1 1 0 0 1
‡Corresponding author. ‡corresponding ‡ ‡C ‡Co ‡Cor BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 11 .:.@. 5 3 1 1 0 0 1
IgG1-Fc fucosylation igg1-fc I Ig IgG IgG1 BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 0 - 1 10 0 0 0 0 1
antigens within antigens a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 .- 2 8 0 0 0 0 1
relation was relation r re rel rela BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 8 0 0 0 0 1
level of level l le lev leve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 9 0 0 0 0 1
antigens within antigens a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 , 1 9 0 0 0 0 1
for anti-HPA-1a for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ---(.) 6 9 0 0 0 0 1
anti-HIV and anti-hiv a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 --(.). 6 9 0 0 0 0 1
Thus, the thus, T Th Thu Thus BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 ,- 2 9 0 0 0 0 1
termined by termined t te ter term BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 no 0 8 0 0 0 0 1
genetics but genetics g ge gen gene BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 - 1 8 0 0 0 0 1
factorial, with factorial, f fa fac fact BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 ,- 2 9 0 0 0 0 1
ing obscure. ing i in ing ing BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 2 0 . 1 2 0 0 0 0 1
Afucosylated IgG afucosylated A Af Afu Afuc BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 1 no 0 10 1 1 0 0 1
attenuated enveloped attenuated a at att atte BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 no 0 9 1 1 0 0 1
To further to T To To To BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 1 no 0 9 1 1 0 0 1
context by context c co con cont BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 no 0 10 1 1 0 0 1
formed, we formed, f fo for form BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 , 1 8 0 0 0 0 1
identical viral identical i id ide iden BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 . 1 10 0 0 0 0 1
First, we first, F Fi Fir Firs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 2 ,- 2 9 0 0 0 0 1
gen (HBsAg)-specific gen g ge gen gen BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 2 2 ()- 3 9 0 0 0 0 1
in humans in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 2 no 0 8 0 0 0 0 1
vaccinated with vaccinated v va vac vacc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 no 0 7 0 0 0 0 1
protein (Fig. protein p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 (.).-- 6 8 0 0 0 0 1
tion levels tion t ti tio tion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 2 , 1 9 0 0 0 0 1
whereas anti-HBsAg whereas w wh whe wher BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 -- 2 8 0 0 0 0 1
was elevated was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 no 0 9 0 0 0 0 1
the HBsAg the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 no 0 7 0 0 0 0 1
either total either e ei eit eith BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 --- 3 9 0 0 0 0 1
fucosylation of fucosylation f fu fuc fuco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 2 no 0 9 0 0 0 0 1
(Fig. 2D). (fig. ( (F (Fi (Fig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 2 (.).,- 6 8 0 0 0 0 1
in individuals in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 2 - 1 8 0 0 0 0 1
tion show tion t ti tio tion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 2 no 0 8 0 0 0 0 1
with that with w wi wit with BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 no 0 9 0 0 0 0 1
subunit vaccination. subunit s su sub subu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 4 . 1 9 0 0 0 0 1
that a that t th tha that BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 no 0 8 0 0 0 0 1
stimulus is stimulus s st sti stim BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 no 0 8 0 0 0 0 1
responses. responses. responses. r re res resp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 . 1 2 0 0 0 0 1
We then we W We We We BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 4 no 0 8 0 0 0 0 1
against mumps against a ag aga agai BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 no 0 8 0 0 0 0 1
after a after a af aft afte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 no 0 9 0 0 0 0 1
live attenuated live l li liv live BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 .- 2 9 0 0 0 0 1
tein subunit tein t te tei tein BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 4 , 1 9 0 0 0 0 1
vaccines showed vaccines v va vac vacc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 - 1 9 0 0 0 0 1
fucosylation compared fucosylation f fu fuc fuco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 4 - 1 9 0 0 0 0 1
fection counterpart fection f fe fec fect BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 4 (..). 5 10 0 0 0 0 1
tendency to tendency t te ten tend BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 no 0 8 0 0 0 0 1
weak for weak w we wea weak BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 ,- 2 8 0 0 0 0 1
sponse showed sponse s sp spo spon BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 4 no 0 9 0 0 0 0 1
by either by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 (. 2 9 0 0 0 0 1
figs. S4 figs. f fi fig figs BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 .). 3 3 0 0 0 0 1
Larsen et larsen L La Lar Lars BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 2 6 .,,() 5 10 1 1 0 0 0
26 February 26 2 26 26 26 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 6 no 0 3 1 1 0 0 0
2 of 2 2 2 2 2 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 2 6 no 0 10 1 1 0 0 0
Patient Patient patient P Pa Pat Pati BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 6 no 0 10 1 0 0 0 1
Sera Sera sera S Se Ser Sera BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 6 no 0 6 1 0 0 0 1
Total IgG total T To Tot Tota BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 6 no 0 10 1 0 0 0 1
Ag specific ag A Ag Ag Ag BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 2 6 no 0 10 1 0 0 0 1
Wash Wash wash W Wa Was Wash BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 2 6 no 0 8 1 1 0 0 1
& & & & & & & BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 6 no 0 3 1 1 0 0 1
Elute Elute elute E El Elu Elut BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 6 no 0 10 1 1 0 0 1
Digestion Digestion digestion D Di Dig Dige BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 6 no 0 10 1 1 0 0 1
Capture Capture capture C Ca Cap Capt BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 6 no 0 8 1 1 0 0 1
ProtG beads protg P Pr Pro Prot BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 6 no 0 10 1 0 0 0 1
Ag-coated plate ag-coated A Ag Ag- Ag-c BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 6 - 1 10 1 0 0 0 1
LC-MS LC-MS lc-ms L LC LC- LC-M BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 6 - 1 10 1 1 0 0 1
Glycopeptides Glycopeptides glycopeptides G Gl Gly Glyc BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 6 no 0 10 1 0 0 0 1
P P p P P P P BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 7 no 0 10 0 0 0 0 1
0 0 0 0 0 0 0 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 2 7 no 0 10 0 0 0 0 1
20 20 20 2 20 20 20 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 7 no 0 10 0 0 0 0 1
40 40 40 4 40 40 40 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 7 no 0 10 0 0 0 0 1
60 60 60 6 60 60 60 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 7 no 0 10 0 0 0 0 1
80 80 80 8 80 80 80 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 7 no 0 10 1 0 0 0 1
100 100 100 1 10 100 100 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 7 no 0 10 1 0 0 0 1
Relative Intensity relative R Re Rel Rela BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 7 [] 2 10 1 0 0 0 1
0 0 0 0 0 0 0 BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 2 7 no 0 10 0 0 0 0 1
20 20 20 2 20 20 20 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 7 no 0 10 0 0 0 0 1
40 40 40 4 40 40 40 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 7 no 0 10 0 0 0 0 1
60 60 60 6 60 60 60 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 7 no 0 10 0 0 0 0 1
80 80 80 8 80 80 80 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 7 no 0 10 0 0 0 0 1
100 100 100 1 10 100 100 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 7 no 0 10 0 0 0 0 1
825 825 825 8 82 825 825 BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 7 no 0 4 0 0 0 0 1
850 850 850 8 85 850 850 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 7 no 0 4 0 0 0 0 1
875 875 875 8 87 875 875 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 7 no 0 4 0 0 0 0 1
900 900 900 9 90 900 900 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 7 no 0 4 0 0 0 0 1
925 925 925 9 92 925 925 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 7 no 0 4 0 0 0 0 1
950 950 950 9 95 950 950 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 7 no 0 4 0 0 0 0 1
975 975 975 9 97 975 975 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 7 no 0 4 0 0 0 0 1
1000 1000 1000 1 10 100 1000 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 2 7 no 0 5 0 0 0 0 1
1025 1025 1025 1 10 102 1025 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 2 7 no 0 5 0 0 0 0 1
1050 m/z 1050 1 10 105 1050 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 2 7 / 1 10 0 0 0 0 1
Relative Intensity relative R Re Rel Rela BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 7 [] 2 10 0 0 0 0 1
0 0 0 0 0 0 0 BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 2 7 no 0 10 0 0 0 0 1
20 20 20 2 20 20 20 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 7 no 0 10 0 0 0 0 1
40 40 40 4 40 40 40 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 7 no 0 10 0 0 0 0 1
60 60 60 6 60 60 60 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 8 no 0 10 0 0 0 0 1
80 80 80 8 80 80 80 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 8 no 0 10 1 0 0 0 1
100 100 100 1 10 100 100 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 8 no 0 10 1 0 0 0 1
0 0 0 0 0 0 0 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 2 8 no 0 10 0 0 0 0 1
20 20 20 2 20 20 20 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 8 no 0 10 0 0 0 0 1
40 40 40 4 40 40 40 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 8 no 0 10 0 0 0 0 1
60 60 60 6 60 60 60 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 8 no 0 10 0 0 0 0 1
80 80 80 8 80 80 80 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 8 no 0 10 0 0 0 0 1
100 100 100 1 10 100 100 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 8 no 0 10 0 0 0 0 1
980 980 980 9 98 980 980 BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 8 no 0 4 0 0 0 0 1
1000 1000 1000 1 10 100 1000 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 2 8 no 0 5 0 0 0 0 1
1020 1020 1020 1 10 102 1020 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 2 8 no 0 5 0 0 0 0 1
1040 1040 1040 1 10 104 1040 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 2 8 no 0 5 0 0 0 0 1
1060 1060 1060 1 10 106 1060 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 2 8 no 0 5 0 0 0 0 1
1080 1080 1080 1 10 108 1080 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 2 8 no 0 5 0 0 0 0 1
1100 m/z 1100 1 11 110 1100 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 2 8 / 1 10 0 0 0 0 1
P P p P P P P BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 8 no 0 10 0 0 0 0 1
P P p P P P P BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 8 no 0 10 0 0 0 0 1
P P p P P P P BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 8 no 0 10 0 0 0 0 1
P P p P P P P BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 8 no 0 10 0 0 0 0 1
P P p P P P P BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 8 no 0 10 0 0 0 0 1
P P p P P P P BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 8 no 0 10 0 0 0 0 1
P P p P P P P BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 8 no 0 10 0 0 0 0 1
P P p P P P P BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 8 no 0 10 0 0 0 0 1
P P p P P P P BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 8 no 0 10 0 0 0 0 1
P P p P P P P BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 8 no 0 10 0 0 0 0 1
P P p P P P P BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 8 no 0 10 0 0 0 0 1
P P p P P P P BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 8 no 0 10 0 0 0 0 1
P P p P P P P BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 8 no 0 10 0 0 0 0 1
P P p P P P P BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 8 no 0 10 0 0 0 0 1
P P p P P P P BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 9 no 0 10 0 0 0 0 1
P P p P P P P BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 9 no 0 10 1 0 0 0 1
P P p P P P P BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 9 no 0 10 0 0 0 0 1
B B b B B B B BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 9 no 0 10 1 0 0 0 1
C C c C C C C BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 9 no 0 10 1 0 0 0 1
Total IgG1 total T To Tot Tota BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 9 no 0 10 1 0 0 0 1
Neutral Neutral neutral N Ne Neu Neut BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 9 no 0 10 1 0 0 0 1
Ag-specific IgG1 ag-specific A Ag Ag- Ag-s BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 9 - 1 10 0 0 0 0 1
Neutral Neutral neutral N Ne Neu Neut BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 9 no 0 10 0 0 0 0 1
Total IgG1 total T To Tot Tota BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 9 no 0 10 1 0 0 0 1
Sialylated Sialylated sialylated S Si Sia Sial BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 9 no 0 10 1 0 0 0 1
Ag-specific IgG1 ag-specific A Ag Ag- Ag-s BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 9 - 1 10 0 0 0 0 1
Sialylated Sialylated sialylated S Si Sia Sial BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 9 no 0 10 0 0 0 0 1
* * * * * * * BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 9 * 1 10 0 0 0 0 1
* * * * * * * BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 9 * 1 10 0 0 0 0 1
A A a A A A A BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 3 9 no 0 10 1 1 0 0 1
N-Acetylglucosamine N-Acetylglucosamine n-acetylglucosamine N N- N-A N-Ac BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 9 - 1 10 0 0 0 0 1
Mannose Mannose mannose M Ma Man Mann BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 9 no 0 4 0 0 0 0 1
Galactose Galactose galactose G Ga Gal Gala BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 9 no 0 5 0 0 0 0 1
Sialic Acid sialic S Si Sia Sial BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 9 () 2 10 0 0 0 0 1
Fucose Fucose fucose F Fu Fuc Fuco BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 9 no 0 3 0 0 0 0 1
* * * * * * * BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 9 * 1 10 0 0 0 0 1
Fig. 1. fig. F Fi Fig Fig. BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 9 ..-.() 6 8 0 0 0 0 1
beads and beads b be bea bead BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 9 --,-,.,, 8 9 0 0 0 0 1
resulting glycopeptides resulting r re res resu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 9 --.() 5 9 0 0 0 0 1
Asn 297 asn A As Asn Asn BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 9 .()()'(,)-(,). 14 10 0 0 0 0 1
indicate non-Fc indicate i in ind indi BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 9 -. 2 1 0 0 0 0 1
RESEARCH | research R RE RES RESE BLOCKSTART PAGEEND NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 1 0 0 0 0 0 3 11 no 0 10 1 1 1 1 0
Afucosylated IgG afucosylated A Af Afu Afuc BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 no 0 10 0 0 0 0 1
COVID-19 patients covid-19 C CO COV COVI BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 - 1 4 0 0 0 0 1
We then we W We We We BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 9 0 0 0 0 1
also plays also a al als also BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 -. 2 9 0 0 0 0 1
Symptoms of symptoms S Sy Sym Symp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 -, 2 8 0 0 0 0 1
ranging from ranging r ra ran rang BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 - 1 9 0 0 0 0 1
infection to infection i in inf infe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 9 0 0 0 0 1
leads to leads l le lea lead BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 9 0 0 0 0 1
(ARDS), often (ards), ( (A (AR (ARD BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 (),(,). 7 9 0 0 0 0 1
Both extreme both B Bo Bot Both BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 10 0 0 0 0 1
responses: Patients responses: r re res resp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 : 1 9 0 0 0 0 1
of relatively of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 , 1 8 0 0 0 0 1
second wave second s se sec seco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 9 0 0 0 0 1
or leads or o or or or BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 - 1 10 0 0 0 0 1
phenotype (20, phenotype p ph phe phen BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 1 (,). 4 9 0 0 0 0 1
response type response r re res resp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 1 - 1 10 0 0 0 0 1
come suggested come c co com come BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 1 no 0 9 0 0 0 0 1
immune system immune i im imm immu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 1 ., 2 9 0 0 0 0 1
no clear no n no no no BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 1 - 1 8 0 0 0 0 1
tinguish between tinguish t ti tin ting BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 1 - 1 8 0 0 0 0 1
munological paths. munological m mu mun muno BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 1 . 1 8 0 0 0 0 1
hypothesis and hypothesis h hy hyp hypo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 1 no 0 8 0 0 0 0 1
other enveloped other o ot oth othe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 1 ,- 2 9 0 0 0 0 1
against SARS-CoV-2 against a ag aga agai BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 1 --(), 5 9 0 0 0 0 1
is expressed is i is is is BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 1 no 0 9 0 0 0 0 1
envelope, were envelope, e en env enve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 1 , 1 8 0 0 0 0 1
levels of levels l le lev leve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 1 .,- 3 9 0 0 0 0 1
sponses against sponses s sp spo spon BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 1 (), 3 9 0 0 0 0 1
which is which w wh whi whic BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 no 0 9 1 0 0 0 1
viral envelope, viral v vi vir vira BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 ,- 2 9 1 0 0 0 1
els of els e el els els BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 2 (.). 4 9 1 0 0 0 1
appeared to appeared a ap app appe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 -- 2 9 1 0 0 0 1
because there because b be bec beca BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 no 0 9 1 0 0 0 1
to SARS-CoV-2 to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 ---- 4 8 1 0 0 0 1
ples, even ples, p pl ple ples BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 2 ,(. 3 9 1 0 0 0 1
S6) (22). s6) S S6 S6) S6) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 2 )().- 5 9 1 0 0 0 1
with ARDS with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 () 2 8 1 0 0 0 1
intensive care intensive i in int inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 () 2 9 1 0 0 0 1
less fucosylated less l le les less BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 no 0 8 1 0 0 0 1
donors consisting donors d do don dono BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 no 0 8 1 0 0 0 1
asymptomatic or asymptomatic a as asy asym BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 2 no 0 8 1 0 0 0 1
(non-ARDS) (Fig. (non-ards) ( (n (no (non BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 2 (-)(.). 7 4 1 0 0 0 1
These decreased these T Th The Thes BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 2 no 0 8 1 0 0 0 1
anti-S IgG anti-s a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 2 - 1 8 1 0 0 0 1
because total because b be bec beca BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 - 1 9 1 0 0 0 1
similar between similar s si sim simi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 no 0 8 1 0 0 0 1
has been has h ha has has BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 no 0 8 1 0 0 0 1
(~94%) (12, (~94%) ( (~ (~9 (~94 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 2 ()(,).,-- 9 9 1 0 0 0 1
sylation and sylation s sy syl syla BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 2 - 1 8 1 0 0 0 1
anti-N responses anti-n a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 2 -(.,)- 6 8 1 0 0 0 1
nificantly increased nificantly n ni nif nifi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 2 , 1 9 1 0 0 0 1
which is which w wh whi whic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 no 0 8 1 0 0 0 1
increased Fc increased i in inc incr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 no 0 8 1 0 0 0 1
in active in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 3 2 (,). 4 8 1 0 0 0 1
Total IgG1-Fc total T To Tot Tota BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 2 - 1 9 1 0 0 0 1
levels were levels l le lev leve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 no 0 9 1 0 0 0 1
patients, which patients, p pa pat pati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 , 1 9 1 0 0 0 1
slight age slight s sl sli slig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 no 0 9 1 0 0 0 1
[non-ARDS donors [non-ards [ [n [no [non BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 2 [-()( 5 8 1 0 0 0 1
55) years 55) 5 55 55) 55) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 2 )(-) 4 8 1 0 0 0 1
years (tables years y ye yea year BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 ()].- 5 8 1 0 0 0 1
lation and lation l la lat lati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 2 (,). 4 9 1 0 0 0 1
Increased galactosylation increased I In Inc Incr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 2 no 0 8 1 0 0 0 1
antigen-specific IgG1-Fc antigen-specific a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 2 -- 2 9 1 0 0 0 1
activity by activity a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 -. 2 9 1 0 0 0 1
galactosylation further galactosylation g ga gal gala BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 2 no 0 8 1 0 0 0 1
afucosylated IgG afucosylated a af afu afuc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 2 no 0 8 1 0 0 0 1
twofold (24). twofold t tw two twof BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 ()., 4 9 1 0 0 0 1
significantly lowered significantly s si sig sign BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 -- 2 9 1 0 0 0 1
S responses s S S S S BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 2 (.), 4 10 1 0 0 0 1
relevance of relevance r re rel rele BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 - 1 8 1 0 0 0 1
bisection affects bisection b bi bis bise BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 2 - 1 9 1 0 0 0 1
plement activity plement p pl ple plem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 2 ()., 4 8 1 0 0 0 1
evidence strongly evidence e ev evi evid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 no 0 8 1 0 0 0 1
and major and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 - 1 9 1 0 0 0 1
Fc glycosylation fc F Fc Fc Fc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 2 . 1 8 1 0 0 0 1
Afucosylated IgG afucosylated A Af Afu Afuc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 2 -- 2 9 1 0 0 0 1
in affinity in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 3 2 ,- 2 9 1 0 0 0 1
panied by panied p pa pan pani BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 2 no 0 9 1 0 0 0 1
response to response r re res resp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 - 1 8 1 0 0 0 1
sponses upon sponses s sp spo spon BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 2 (,,,). 6 9 1 0 0 0 1
lowered Fc lowered l lo low lowe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 - 1 9 1 0 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 no 0 8 1 0 0 0 1
role through role r ro rol role BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 , 1 8 1 0 0 0 1
previously been previously p pr pre prev BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 (). 3 8 1 0 0 0 1
dengue, non-neutralizing dengue, d de den deng BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 2 ,- 2 9 1 0 0 0 1
formed to formed f fo for form BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 no 0 9 1 0 0 0 1
serotypes also serotypes s se ser sero BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 2 no 0 8 1 0 0 0 1
core-fucosylated IgG. core-fucosylated c co cor core BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 2 -. 2 9 1 0 0 0 1
of preventing of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 , 1 9 1 0 0 0 1
dengue hemorrhagic dengue d de den deng BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 2 - 1 8 1 0 0 0 1
mediated overreactions mediated m me med medi BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 (). 3 8 1 0 0 0 1
Larsen et larsen L La Lar Lars BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 3 8 .,,() 5 10 1 1 0 0 0
26 February 26 2 26 26 26 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 8 no 0 3 1 1 0 0 0
3 of 3 3 3 3 3 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 3 8 no 0 10 1 1 0 0 0
A A a A A A A BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 3 8 no 0 10 1 1 0 0 1
D D d D D D D BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 8 no 0 10 0 0 0 0 1
E E e E E E E BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 8 no 0 10 0 0 0 0 1
B B b B B B B BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 8 no 0 10 1 1 0 0 1
C C c C C C C BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 8 no 0 10 1 1 0 0 1
Fig. 2. fig. F Fi Fig Fig. BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 8 ..,() 5 8 0 0 0 0 1
viruses or viruses v vi vir viru BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 ,.()- 5 9 0 0 0 0 1
total (solid total t to tot tota BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 ()-()- 6 9 0 0 0 0 1
group of group g gr gro grou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 :()-;();() 10 9 0 0 0 0 1
antigens from antigens a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 8 ;(),()() 8 10 0 0 0 0 1
with recombinant with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 ;()() 5 9 0 0 0 0 1
mumps virus mumps m mu mum mump BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 (). 3 9 0 0 0 0 1
replicate [(A) replicate r re rep repl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 8 [()--,(),(),() 14 10 0 0 0 0 1
naturally infected naturally n na nat natu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 ,() 3 9 0 0 0 0 1
infected individuals infected i in inf infe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 ] 1 9 0 0 0 0 1
LC-MS run lc-ms L LC LC- LC-M BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 8 -(.). 5 9 0 0 0 0 1
paired t paired p pa pai pair BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 8 (),(),(),-- 11 9 0 0 0 0 1
t tests t t t t t BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 3 8 ()(). 5 9 0 0 0 0 1
significant differences significant s si sig sign BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 .*.,**.,****.. 14 6 0 0 0 0 1
RESEARCH | research R RE RES RESE BLOCKSTART PAGEEND NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 1 0 0 0 0 0 4 11 no 0 10 1 1 1 0 0
Larsen et larsen L La Lar Lars BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 4 0 .,,() 5 10 1 1 0 0 0
26 February 26 2 26 26 26 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 4 0 no 0 10 1 1 0 0 0
4 of 4 4 4 4 4 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 4 0 no 0 10 1 1 0 0 0
A A a A A A A BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 4 0 no 0 10 1 1 0 0 1
B B b B B B B BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 0 no 0 10 1 1 0 0 1
C C c C C C C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 0 no 0 10 1 1 0 0 1
D D d D D D D BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 0 no 0 10 1 1 0 0 1
E E e E E E E BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 0 no 0 10 0 0 0 0 1
F F f F F F F BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 0 no 0 10 0 0 0 0 1
G G g G G G G BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 0 no 0 10 0 0 0 0 1
H H h H H H H BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 0 no 0 10 0 0 0 0 1
I I i I I I I BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 0 no 0 10 0 0 0 0 1
J J j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 0 no 0 10 0 0 0 0 1
K K k K K K K BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 0 no 0 10 0 0 0 0 1
L L l L L L L BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 0 no 0 10 0 0 0 0 1
M M m M M M M BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 0 no 0 10 0 0 0 0 1
N N n N N N N BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 0 no 0 10 0 0 0 0 1
O O o O O O O BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 0 no 0 10 0 0 0 0 1
P P p P P P P BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 0 no 0 10 0 0 0 0 1
Fig. 3. fig. F Fi Fig Fig. BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 1 ..- 3 8 0 0 0 0 1
critically ill critically c cr cri crit BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 1 -.(),(), 8 8 0 0 0 0 1
(C) sialylation, (c) ( (C (C) (C) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 1 (),()-,-, 9 9 0 0 0 0 1
ARDS patients ards A AR ARD ARDS BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 1 - 1 8 0 0 0 0 1
with mild with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 1 .()- 4 8 0 0 0 0 1
fucosylation and fucosylation f fu fuc fuco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 1 [()()]-[()()]-[(), 18 10 0 0 0 0 1
(F), (I), (f), ( (F (F) (F), BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 1 (),(),()][(),(),(),()]-. 24 8 0 0 0 0 1
(M) Correlation (m) ( (M (M) (M) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 1 ()---.() 8 9 0 0 0 0 1
examples of examples e ex exa exam BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 1 - 1 7 0 0 0 0 1
stimulation with stimulation s st sti stim BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 1 : 1 8 0 0 0 0 1
polycytidylic acid polycytidylic p po pol poly BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 1 [(:)].()- 9 9 0 0 0 0 1
and degrees and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 1 --.() 5 9 0 0 0 0 1
concentrations and concentrations c co con conc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 1 --. 3 9 0 0 0 0 1
biological replicate: biological b bi bio biol BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 1 :,-[()()], 10 9 0 0 0 0 1
n = n n n n n BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 4 6 -,[()()]. 9 9 0 0 0 0 1
technical replicates technical t te tec tech BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 6 -..[(),(),(),()] 16 9 0 0 0 0 1
data are data d da dat data BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 6 no 0 9 0 0 0 0 1
technical experiments. technical t te tec tech BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 6 .(),.()- 8 9 0 0 0 0 1
production by production p pr pro prod BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 4 6 ,() 3 8 0 0 0 0 1
representing a representing r re rep repr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 6 ... 3 10 0 0 0 0 1
CRP and crp C CR CRP CRP BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 6 -- 2 8 0 0 0 0 1
Meso Scale meso M Me Mes Meso BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 6 ,[()()]. 8 9 0 0 0 0 1
Statistical analyses statistical S St Sta Stat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 6 -- 2 8 0 0 0 0 1
Bonferroni correction bonferroni B Bo Bon Bonf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 6 no 0 9 0 0 0 0 1
cytokine secretion cytokine c cy cyt cyto BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 6 .'() 4 9 0 0 0 0 1
and (P). and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 6 ().--, 6 9 0 0 0 0 1
a Pearson's a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 4 6 '. 2 9 0 0 0 0 1
shown. *P shown. s sh sho show BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 6 .*.,**.,***.,****.. 19 6 0 0 0 0 1
RESEARCH | research R RE RES RESE BLOCKSTART PAGEEND NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 1 0 0 0 0 0 4 11 no 0 10 1 1 1 0 0
Fucosylation levels fucosylation F Fu Fuc Fuco BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 - 1 10 1 1 0 0 1
at seroconversion at a at at at BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 4 1 1 0 0 1
ARDS patients ards A AR ARD ARDS BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 no 0 7 1 0 0 0 1
after ICU after a af aft afte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 ,- 2 8 1 0 0 0 1
were convalescent were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 . 1 8 1 0 0 0 1
In order in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 4 0 no 0 8 1 0 0 0 1
bias in bias b bi bia bias BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 -- 2 8 1 0 0 0 1
terns over terns t te ter tern BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 , 1 8 1 0 0 0 1
samples from samples s sa sam samp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 4 0 (). 3 8 1 0 0 0 1
Fc fucosylation fc F Fc Fc Fc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 no 0 8 1 0 0 0 1
is stable is i is is is BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 9 1 0 0 0 1
natural booster natural n na nat natu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 (,) 3 8 1 0 0 0 1
or blood or o or or or BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 (). 3 8 1 0 0 0 1
for anti-CMV for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 --(.). 6 8 1 0 0 0 1
By contrast, by B By By By BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 , 1 9 1 0 0 0 1
were already were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 -- 2 8 1 0 0 0 1
the first the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 (., 3 8 1 0 0 0 1
to L, to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 ,.). 4 8 1 0 0 0 1
changes in changes c ch cha chan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 4 0 (.) 3 9 1 0 0 0 1
line with line l li lin line BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 - 1 8 1 0 0 0 1
nizations are nizations n ni niz niza BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 no 0 8 1 0 0 0 1
rise in rise r ri ris rise BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 -- 2 9 1 0 0 0 1
and sialylation and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 (,)., 5 9 1 0 0 0 1
all ARDS all a al all all BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 8 1 0 0 0 1
of anti-S of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 -- 2 8 1 0 0 0 1
ARDS patients. ards A AR ARD ARDS BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 . 1 8 1 0 0 0 1
time in time t ti tim time BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 ,- 2 8 1 0 0 0 1
parable with parable p pa par para BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 - 1 7 1 0 0 0 1
(Fig. 3, (fig. ( (F (Fi (Fig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 (.,). 5 8 1 0 0 0 1
levels were levels l le lev leve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 7 1 0 0 0 1
rises in rises r ri ris rise BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 (.,,., 6 10 1 0 0 0 1
and B), and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 ), 2 8 1 0 0 0 1
the non-ARDS the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 -. 2 8 1 0 0 0 1
observed for observed o ob obs obse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 -(., 4 8 1 0 0 0 1
L). Reduced l). L L) L). L). BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 ).- 3 8 1 0 0 0 1
were also were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 , 1 8 1 0 0 0 1
to a to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 -(., 4 9 1 0 0 0 1
K, and k, K K, K, K, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 ,.). 4 8 1 0 0 0 1
the fucosylation the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 - 1 9 1 0 0 0 1
cohort may cohort c co coh coho BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 no 0 8 1 0 0 0 1
bystander effects bystander b by bys byst BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 ().,- 5 9 1 0 0 0 1
ating in ating a at ati atin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 - 1 8 1 0 0 0 1
ilar environmental ilar i il ila ilar BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 - 1 9 1 0 0 0 1
cells and cells c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 .- 2 8 1 0 0 0 1
anti-S and anti-s a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 --(. 4 9 1 0 0 0 1
3M) with 3m) 3 3M 3M) 3M) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 ) 1 8 1 0 0 0 1
anti-S (P anti-s a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 -(.). 5 9 1 0 0 0 1
also observed also a al als also BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 , 1 8 1 0 0 0 1
with similar with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 - 1 7 1 0 0 0 1
anti-N IgG anti-n a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 -(.). 5 8 1 0 0 0 1
antigen-specific IgG1-Fc antigen-specific a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 -- 2 7 1 0 0 0 1
and sialylation and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 8 1 0 0 0 1
that have that t th tha that BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 8 1 0 0 0 1
features of features f fe fea feat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 7 1 0 0 0 1
responses (18, responses r re res resp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 (,).- 5 8 1 0 0 0 1
remained stable remained r re rem rema BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 8 1 0 0 0 1
period (figs. period p pe per peri BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 (.). 4 5 1 0 0 0 1
Afucosylated IgG afucosylated A Af Afu Afuc BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 3 no 0 10 1 0 0 0 1
in COVID-19 in i in in in BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 3 - 1 2 1 0 0 0 1
We then we W We We We BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 3 - 1 9 1 1 0 0 1
SARS-CoV-2 antibodies sars-cov-2 S SA SAR SARS BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 3 -- 2 9 1 1 0 0 1
the strong the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 3 no 0 9 1 1 0 0 1
in ARDS in i in in in BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 3 . 1 10 1 1 0 0 1
front-line scavengers front-line f fr fro fron BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 - 1 9 1 0 0 0 1
FcgRIIIa, the fcgriiia, F Fc Fcg FcgR BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 4 , 1 8 1 0 0 0 1
for afucosylated for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 ., 2 9 1 0 0 0 1
potential to potential p po pot pote BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 no 0 8 1 0 0 0 1
pro-inflammatory cytokine pro-inflammatory p pr pro pro- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 4 --(-), 6 9 1 0 0 0 1
the cytokine the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 - 1 10 1 0 0 0 1
responses in responses r re res resp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 ()., 4 8 1 0 0 0 1
together with together t to tog toge BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 -(), 4 9 1 0 0 0 1
enhanced IL-6 enhanced e en enh enha BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 - 1 8 1 0 0 0 1
in vitro, in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 4 , 1 9 1 0 0 0 1
and highly and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 ,- 2 9 1 0 0 0 1
inently in inently i in ine inen BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 4 (. 2 8 1 0 0 0 1
figs. S8 figs. f fi fig figs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 .).- 4 9 1 0 0 0 1
relation between relation r re rel rela BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 -- 2 8 1 0 0 0 1
and both and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 -- 2 8 1 0 0 0 1
(CRP) concentrations (crp) ( (C (CR (CRP BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 4 ()(.,). 7 8 1 0 0 0 1
agrees with agrees a ag agr agre BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 no 0 8 1 0 0 0 1
anti-SARS-CoV-2 IgG anti-sars-cov-2 a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 4 --- 3 8 1 0 0 0 1
in COVID-19 in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 4 -. 2 8 1 0 0 0 1
plasma IL-6 plasma p pl pla plas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 - 1 8 1 0 0 0 1
time when time t ti tim time BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 -, 2 8 1 0 0 0 1
which suggested which w wh whi whic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 (., 3 9 1 0 0 0 1
and B). and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 ).- 3 9 1 0 0 0 1
temporal pattern temporal t te tem temp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 (.).,- 6 9 1 0 0 0 1
lated and lated l la lat late BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 4 - 1 8 1 0 0 0 1
anti-N IgG anti-n a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 4 - 1 8 1 0 0 0 1
exaggerated release exaggerated e ex exa exag BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 - 1 8 1 0 0 0 1
kines and kines k ki kin kine BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 4 no 0 8 1 0 0 0 1
because of because b be bec beca BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 no 0 9 1 0 0 0 1
FcgRIIIa (24) fcgriiia F Fc Fcg FcgR BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 4 (). 3 8 1 0 0 0 1
increase of increase i in inc incr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 - 1 8 1 0 0 0 1
in the in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 4 -(.,, 5 8 1 0 0 0 1
fig. S15). fig. f fi fig fig. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 .). 3 2 1 0 0 0 1
Discussion Discussion discussion D Di Dis Disc BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 6 no 0 10 0 0 0 0 1
Our results our O Ou Our Our BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 6 no 0 8 0 0 0 0 1
IgG1 immune igg1 I Ig IgG IgG1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 6 - 1 8 0 0 0 0 1
embedded antigens embedded e em emb embe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 no 0 8 0 0 0 0 1
proteins of proteins p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 no 0 8 0 0 0 0 1
on enveloped on o on on on BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 ( 1 8 0 0 0 0 1
enveloped virus enveloped e en env enve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 no 0 9 0 0 0 0 1
their first their t th the thei BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 ). 2 10 0 0 0 0 1
with soluble with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 - 1 8 0 0 0 0 1
oped viruses oped o op ope oped BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 6 no 0 8 0 0 0 0 1
with high with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 - 1 9 0 0 0 0 1
consistently observed. consistently c co con cons BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 . 1 8 0 0 0 0 1
afucosylated anti-N afucosylated a af afu afuc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 6 --, 3 9 0 0 0 0 1
this was this t th thi this BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 no 0 9 0 0 0 0 1
seroconversion. seroconversion. seroconversion. s se ser sero BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 6 . 1 3 0 0 0 0 1
We hypothesize we W We We We BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 6 - 1 8 0 0 0 0 1
membranes are membranes m me mem memb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 no 0 8 0 0 0 0 1
by combining by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 no 0 8 0 0 0 0 1
by the by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 no 0 9 0 0 0 0 1
receptor-ligand pair(s). receptor-ligand r re rec rece BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 6 -().-- 6 9 0 0 0 0 1
nism would nism n ni nis nism BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 6 no 0 9 0 0 0 0 1
long-lasting afucosylated long-lasting l lo lon long BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 - 1 9 0 0 0 0 1
would not would w wo wou woul BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 , 1 9 0 0 0 0 1
internal proteins internal i in int inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 ,- 2 9 0 0 0 0 1
enveloped viruses enveloped e en env enve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 (.).,- 6 9 0 0 0 0 1
ferential antigen ferential f fe fer fere BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 6 no 0 8 0 0 0 0 1
complex and complex c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 no 0 9 0 0 0 0 1
from antigen-presenting from f fr fro from BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 -,,/ 4 9 0 0 0 0 1
cytokines. This cytokines. c cy cyt cyto BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 6 .- 2 9 0 0 0 0 1
SARS-CoV-2 responses sars-cov-2 S SA SAR SARS BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 6 --- 3 8 0 0 0 0 1
tantly with tantly t ta tan tant BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 7 -, 2 9 1 0 0 0 1
that proximal that t th tha that BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 - 1 8 1 0 0 0 1
environment can environment e en env envi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 7 . 1 8 1 0 0 0 1
This work this T Th Thi This BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 7 no 0 8 1 0 0 0 1
B cell b B B B B BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 5 7 - 1 9 1 0 0 0 1
membrane may membrane m me mem memb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 no 0 9 1 0 0 0 1
to trigger to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 no 0 8 1 0 0 0 1
amounts of amounts a am amo amou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 - 1 8 1 0 0 0 1
(17). This (17). ( (1 (17 (17) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 7 ().- 4 9 1 0 0 0 1
tion levels tion t ti tio tion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 7 no 0 8 1 0 0 0 1
for distinct for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 - 1 8 1 0 0 0 1
ual against ual u ua ual ual BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 7 .- 2 9 1 0 0 0 1
ference in ference f fe fer fere BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 5 7 - 1 8 1 0 0 0 1
afucosylated responses afucosylated a af afu afuc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 7 no 0 8 1 0 0 0 1
patients contributes patients p pa pat pati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 - 1 9 1 0 0 0 1
ease severity, ease e ea eas ease BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 , 1 9 1 0 0 0 1
alloimmune cytopenias alloimmune a al all allo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 7 (,,) 4 9 1 0 0 0 1
(15). Here, (15). ( (1 (15 (15) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 7 ()., 4 9 1 0 0 0 1
pathogenesis of pathogenesis p pa pat path BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 7 -., 3 9 1 0 0 0 1
may potentially may m ma may may BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 1 0 0 5 7 - 1 9 1 0 0 0 1
ries and ries r ri rie ries BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 7 no 0 8 1 0 0 0 1
minimizing this minimizing m mi min mini BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 . 1 7 1 0 0 0 1
IgG-Fc afucosylation igg-fc I Ig IgG IgG- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 7 -- 2 8 1 0 0 0 1
mune responses. mune m mu mun mune BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 7 .,- 3 8 1 0 0 0 1
natural killer natural n na nat natu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 (),,- 5 9 1 0 0 0 1
rophages as rophages r ro rop roph BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 7 -- 2 9 1 0 0 0 1
ulocytes are ulocytes u ul ulo uloc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 7 . 1 9 1 0 0 0 1
This response this T Th Thi This BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 7 - 1 8 1 0 0 0 1
sponses, such sponses, s sp spo spon BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 7 ,(), 4 9 1 0 0 0 1
achieved with achieved a ac ach achi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 no 0 9 1 0 0 0 1
viral vaccine viral v vi vir vira BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 () 2 9 1 0 0 0 1
which vaccine-based which w wh whi whic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 -. 2 8 1 0 0 0 1
However, this however, H Ho How Howe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 7 , 1 9 1 0 0 0 1
undesirable exaggerated undesirable u un und unde BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 , 1 8 1 0 0 0 1
case for case c ca cas case BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 7 ()--. 5 9 1 0 0 0 1
Attenuated virus attenuated A At Att Atte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 7 no 0 9 1 0 0 0 1
of SARS-CoV of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 - 1 8 1 0 0 0 1
antibody-dependent enhanced antibody-dependent a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 7 -() 3 8 1 0 0 0 1
mimicking pathologies mimicking m mi mim mimi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 - 1 9 1 0 0 0 1
CoV-2 patients cov-2 C Co CoV CoV- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 7 -(). 4 9 1 0 0 0 1
protein vaccines protein p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 , 1 9 1 0 0 0 1
in rat in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 7 --(), 5 9 1 0 0 0 1
vaccine also vaccine v va vac vacc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 no 0 10 1 0 0 0 1
that can that t th tha that BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 . 1 8 1 0 0 0 1
The afucosylation the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 7 -- 2 8 1 0 0 0 1
tribute to tribute t tr tri trib BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 - 1 9 1 0 0 0 1
subset of subset s su sub subs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 ,., 3 9 1 0 0 0 1
although they although a al alt alth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 , 1 8 1 0 0 0 1
potentially behave potentially p po pot pote BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 - 1 9 1 0 0 0 1
may contribute may m ma may may BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 1 0 0 5 7 no 0 9 1 0 0 0 1
(33). As (33). ( (3 (33 (33) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 7 ()., 4 9 1 0 0 0 1
the development the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 no 0 8 1 0 0 0 1
Ig (IVIg), ig I Ig Ig Ig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 7 (),, 4 8 1 0 0 0 1
therapies. In therapies. t th the ther BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 ., 2 9 1 0 0 0 1
afucosylated antibodies afucosylated a af afu afuc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 7 no 0 8 1 0 0 0 1
of SARS-CoV-2 of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 --- 3 8 1 0 0 0 1
portunities for portunities p po por port BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 7 -. 2 8 1 0 0 0 1
Thus, attempts thus, T Th Thu Thus BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 7 ,-- 3 9 1 0 0 0 1
ments should ments m me men ment BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 7 no 0 8 1 0 0 0 1
in fucosylated in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 7 ---. 4 8 1 0 0 0 1
This may this T Th Thi This BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 7 no 0 8 1 0 0 0 1
and promote and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 , 1 9 1 0 0 0 1
preferentially before preferentially p pr pre pref BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 no 0 9 1 0 0 0 1
IgG responses. igg I Ig IgG IgG BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 7 . 1 3 1 0 0 0 1
Larsen et larsen L La Lar Lars BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 6 11 .,,() 5 10 1 1 0 0 0
26 February 26 2 26 26 26 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 11 no 0 3 1 1 0 0 0
5 of 5 5 5 5 5 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 6 11 no 0 10 1 1 0 0 0
RESEARCH | research R RE RES RESE BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 1 0 0 0 0 0 6 11 no 0 10 1 1 1 0 0
Materials and materials M Ma Mat Mate BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 no 0 10 0 0 0 0 1
Patient samples patient P Pa Pat Pati BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 no 0 7 0 0 0 0 1
Healthy blood healthy H He Hea Heal BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 , 1 8 0 0 0 0 1
Amsterdam, the amsterdam, A Am Ams Amst BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 ,, 2 8 0 0 0 0 1
analyze parvovirus analyze a an ana anal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 (), 3 9 0 0 0 0 1
(n = (n ( (n (n (n BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 (,- 3 10 0 0 0 0 1
vaccine), mumps vaccine), v va vac vacc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 ),(- 4 8 0 0 0 0 1
tion, n tion, t ti tio tion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 ,-), 4 9 0 0 0 0 1
antibodies (n antibodies a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 (, 2 9 0 0 0 0 1
HBsAg vaccination). hbsag H HB HBs HBsA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 ).-- 4 9 0 0 0 0 1
been described been b be bee been BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 ().- 4 8 0 0 0 0 1
(n = (n ( (n (n (n BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 () 2 8 0 0 0 0 1
on HIV on o on on on BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 () 2 8 0 0 0 0 1
to analyze to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 -- 2 8 0 0 0 0 1
tion. Peripheral tion. t ti tio tion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 . 1 9 0 0 0 0 1
CMV-specific antibodies cmv-specific C CM CMV CMV- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 -() 3 8 0 0 0 0 1
same cohort same s sa sam same BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 - 1 8 0 0 0 0 1
the Finnish the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 , 1 9 0 0 0 0 1
Immunology Laboratory, immunology I Im Imm Immu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 ,, 2 8 0 0 0 0 1
and the and a an and and BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 .- 2 8 0 0 0 0 1
CoV-2 patient cov-2 C Co CoV CoV- BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 1 - 1 9 0 0 0 0 1
the Amsterdam the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 no 0 8 0 0 0 0 1
included, as included, i in inc incl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 , 1 8 0 0 0 0 1
found seropositive found f fo fou foun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 --, 3 8 0 0 0 0 1
longitudinal samples longitudinal l lo lon long BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 no 0 8 0 0 0 0 1
monitored after monitored m mo mon moni BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 (). 3 8 0 0 0 0 1
summary of summary s su sum summ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 no 0 9 0 0 0 0 1
in table in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 6 1 , 1 9 0 0 0 0 1
the ARDS the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 -( 2 8 0 0 0 0 1
requiring ventilation). requiring r re req requ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 ).- 3 9 0 0 0 0 1
ducted in ducted d du duc duct BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 1 no 0 10 0 0 0 0 1
set out set s se set set BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 no 0 9 0 0 0 0 1
participants provided participants p pa par part BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 . 1 9 0 0 0 0 1
The study the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 1 no 0 7 0 0 0 0 1
Medical Center medical M Me Med Medi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 1 no 0 8 0 0 0 0 1
Committee of committee C Co Com Comm BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 1 . 1 8 0 0 0 0 1
Purification of purification P Pu Pur Puri BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 3 - 1 10 1 1 0 0 1
CMV-specific antibodies cmv-specific C CM CMV CMV- BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 3 - 1 9 1 1 0 0 1
antigen-coated plates antigen-coated a an ant anti BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 3 -(, 3 10 1 1 0 0 1
Cytomegalovirus IgG, cytomegalovirus C Cy Cyt Cyto BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 3 ,,). 4 8 0 0 0 0 1
(20 ml) (20 ( (2 (20 (20 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 3 ()() 4 9 0 0 0 0 1
from the from f fr fro from BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 3 no 0 8 0 0 0 0 1
for 1 for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 3 . 1 9 0 0 0 0 1
from the from f fr fro from BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 3 - 1 9 0 0 0 0 1
were used were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 3 . 1 8 0 0 0 0 1
three times three t th thr thre BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 3 (), 3 10 0 0 0 0 1
twice with twice t tw twi twic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 3 () 2 8 0 0 0 0 1
(300 ml), (300 ( (3 (30 (300 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 3 (),(). 6 9 0 0 0 0 1
The bound the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 3 no 0 8 0 0 0 0 1
100 ml 100 1 10 100 100 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 3 . 1 7 0 0 0 0 1
found in found f fo fou foun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 3 - 1 8 0 0 0 0 1
negative patient negative n ne neg nega BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 3 . 1 5 0 0 0 0 1
Purification of purification P Pu Pur Puri BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 4 - 1 10 1 0 0 0 1
virus-specific antibodies virus-specific v vi vir viru BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 - 1 9 1 0 0 0 1
Ag-specific antibodies ag-specific A Ag Ag- Ag-s BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 4 - 1 8 1 1 0 0 1
antigen-coated plates antigen-coated a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 4 -(, 3 9 1 1 0 0 1
Measles IgG measles M Me Mea Meas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 4 ,, 2 7 1 1 0 0 1
Germany). Sera germany). G Ge Ger Germ BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 4 ).() 4 10 1 1 0 0 1
Larsen et larsen L La Lar Lars BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 6 4 .,,() 5 10 1 1 0 0 0
26 February 26 2 26 26 26 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 4 no 0 3 1 1 0 0 0
6 of 6 6 6 6 6 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 6 5 no 0 10 1 1 0 0 0
0 0 0 0 0 0 0 BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 6 5 no 0 1 0 0 0 0 1
2 0 2 2 2 2 2 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 6 5 no 0 10 0 0 0 0 1
0 0 0 0 0 0 0 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 6 5 no 0 10 0 0 0 0 1
50 50 50 5 50 50 50 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 5 no 0 10 0 0 0 0 1
100 100 100 1 10 100 100 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 5 no 0 10 0 0 0 0 1
150 150 150 1 15 150 150 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 5 no 0 10 0 0 0 0 1
200 200 200 2 20 200 200 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 5 no 0 10 1 0 0 0 1
IL-6 (pg/ml) il-6 I IL IL- IL-6 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 5 -(/) 4 10 0 0 0 0 1
0 0 0 0 0 0 0 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 6 5 no 0 1 0 0 0 0 1
2 0 2 2 2 2 2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 6 5 no 0 10 0 0 0 0 1
2 0 2 2 2 2 2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 6 5 no 0 10 0 0 0 0 1
20 40 20 2 20 20 20 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 5 no 0 7 0 0 0 0 1
2 0 2 2 2 2 2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 6 5 no 0 10 0 0 0 0 1
2 0 2 2 2 2 2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 6 5 no 0 10 0 0 0 0 1
2 0 2 2 2 2 2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 6 5 no 0 10 0 0 0 0 1
2 0 2 2 2 2 2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 6 5 no 0 10 0 0 0 0 1
2 0 2 2 2 2 2 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 6 5 no 0 7 0 0 0 0 1
Patient ID: patient P Pa Pat Pati BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 6 : 1 10 1 1 0 0 1
# # # # # # # BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 6 # 1 10 1 1 0 0 1
# # # # # # # BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 6 # 1 10 1 1 0 0 1
50 50 50 5 50 50 50 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 6 no 0 10 1 0 0 0 1
60 60 60 6 60 60 60 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 6 no 0 10 1 0 0 0 1
70 70 70 7 70 70 70 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 6 no 0 10 1 0 0 0 1
80 80 80 8 80 80 80 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 6 no 0 10 1 1 0 0 1
90 90 90 9 90 90 90 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 6 no 0 10 1 1 0 0 1
100 100 100 1 10 100 100 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 6 no 0 10 1 1 0 0 1
Patient ID: patient P Pa Pat Pati BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 6 : 1 10 1 1 0 0 1
anti-S and anti-s a an ant anti BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 6 --() 4 10 1 0 0 0 1
# # # # # # # BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 6 # 1 10 1 1 0 0 1
0 0 0 0 0 0 0 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 6 6 no 0 1 0 0 0 0 1
2 0 2 2 2 2 2 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 6 6 no 0 10 0 0 0 0 1
0 0 0 0 0 0 0 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 6 6 no 0 10 0 0 0 0 1
50 50 50 5 50 50 50 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 6 no 0 10 0 0 0 0 1
100 100 100 1 10 100 100 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 6 no 0 10 0 0 0 0 1
150 150 150 1 15 150 150 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 6 no 0 10 0 0 0 0 1
200 200 200 2 20 200 200 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 6 no 0 10 0 0 0 0 1
IL-6 (pg/ml) il-6 I IL IL- IL-6 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 -(/) 4 10 0 0 0 0 1
0 0 0 0 0 0 0 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 6 6 no 0 1 0 0 0 0 1
2 0 2 2 2 2 2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 6 6 no 0 8 0 0 0 0 1
2 0 2 2 2 2 2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 6 6 no 0 8 0 0 0 0 1
20 40 20 2 20 20 20 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 6 no 0 7 0 0 0 0 1
2 0 2 2 2 2 2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 6 6 no 0 8 0 0 0 0 1
20 40 20 2 20 20 20 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 6 no 0 7 0 0 0 0 1
2 0 2 2 2 2 2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 6 6 no 0 10 0 0 0 0 1
2 0 2 2 2 2 2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 6 6 no 0 8 0 0 0 0 1
2 0 2 2 2 2 2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 6 6 no 0 8 0 0 0 0 1
20 40 20 2 20 20 20 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 6 no 0 6 0 0 0 0 1
non-ARDS 105 non-ards n no non non- BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 7 - 1 10 0 0 0 0 1
# # # # # # # BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 7 # 1 10 0 0 0 0 1
non-ARDS: 106 non-ards: n no non non- BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 7 -: 2 10 0 0 0 0 1
# # # # # # # BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 7 # 1 10 0 0 0 0 1
Patient ID: patient P Pa Pat Pati BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 7 : 1 10 1 1 0 0 1
Patient ID: patient P Pa Pat Pati BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 7 : 1 9 1 1 0 0 1
# # # # # # # BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 7 # 1 10 1 0 0 0 1
# # # # # # # BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 7 # 1 10 1 1 0 0 1
Patient ID: patient P Pa Pat Pati BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 7 : 1 9 1 1 0 0 1
Patient ID: patient P Pa Pat Pati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 7 : 1 10 1 1 0 0 1
Patient ID: patient P Pa Pat Pati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 7 : 1 10 1 1 0 0 1
Patient ID: patient P Pa Pat Pati BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 7 : 1 9 1 1 0 0 1
A A a A A A A BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 7 7 no 0 10 1 1 0 0 1
B B b B B B B BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 7 no 0 10 1 0 0 0 1
Patient ID: patient P Pa Pat Pati BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 7 : 1 10 1 1 0 0 1
Patient ID: patient P Pa Pat Pati BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 7 : 1 10 1 1 0 0 1
# # # # # # # BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 7 # 1 10 1 1 0 0 1
Patient ID: patient P Pa Pat Pati BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 7 : 1 10 1 1 0 0 1
Days since days D Da Day Days BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 7 no 0 10 0 0 0 0 1
50 50 50 5 50 50 50 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 7 no 0 10 0 0 0 0 1
60 60 60 6 60 60 60 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 7 no 0 10 0 0 0 0 1
70 70 70 7 70 70 70 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 7 no 0 10 0 0 0 0 1
80 80 80 8 80 80 80 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 7 no 0 10 0 0 0 0 1
90 90 90 9 90 90 90 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 7 no 0 10 0 0 0 0 1
100 100 100 1 10 100 100 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 7 no 0 10 0 0 0 0 1
non-ARDS 101 non-ards n no non non- BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 7 - 1 10 0 0 0 0 1
anti-S and anti-s a an ant anti BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 8 --() 4 10 0 0 0 0 1
# # # # # # # BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 8 # 1 10 0 0 0 0 1
# # # # # # # BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 8 # 1 10 0 0 0 0 1
non-ARDS 102 non-ards n no non non- BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 8 - 1 10 0 0 0 0 1
# # # # # # # BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 8 # 1 10 0 0 0 0 1
# # # # # # # BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 8 # 1 10 0 0 0 0 1
non-ARDS 103 non-ards n no non non- BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 8 - 1 10 0 0 0 0 1
# # # # # # # BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 8 # 1 10 0 0 0 0 1
non-ARDS 104 non-ards n no non non- BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 8 - 1 10 0 0 0 0 1
# # # # # # # BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 8 # 1 10 0 0 0 0 1
non-ARDS: 107 non-ards: n no non non- BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 8 -: 2 10 0 0 0 0 1
# # # # # # # BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 8 # 1 10 0 0 0 0 1
# # # # # # # BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 8 # 1 10 0 0 0 0 1
non-ARDS 109 non-ards n no non non- BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 8 - 1 10 0 0 0 0 1
# # # # # # # BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 8 # 1 10 0 0 0 0 1
non-ARDS: 112 non-ards: n no non non- BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 8 -: 2 10 0 0 0 0 1
# # # # # # # BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 8 # 1 10 0 0 0 0 1
0 0 0 0 0 0 0 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 7 8 no 0 2 0 0 0 0 1
2 0 2 2 2 2 2 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 7 8 no 0 10 0 0 0 0 1
non-ARDS: 113 non-ards: n no non non- BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 8 -: 2 10 0 0 0 0 1
0 0 0 0 0 0 0 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 7 8 no 0 1 0 0 0 0 1
2 0 2 2 2 2 2 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 7 8 no 0 10 0 0 0 0 1
0 0 0 0 0 0 0 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 7 8 no 0 10 0 0 0 0 1
150 150 150 1 15 150 150 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 8 no 0 10 0 0 0 0 1
300 300 300 3 30 300 300 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 8 no 0 10 0 0 0 0 1
450 450 450 4 45 450 450 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 8 no 0 10 0 0 0 0 1
600 600 600 6 60 600 600 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 8 no 0 10 0 0 0 0 1
CRP (mg/L) crp C CR CRP CRP BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 8 (/) 3 10 0 0 0 0 1
C C c C C C C BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 8 no 0 10 0 0 0 0 1
D D d D D D D BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 8 no 0 10 0 0 0 0 1
Days since days D Da Day Days BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 9 no 0 10 0 0 0 0 1
Patient ID: patient P Pa Pat Pati BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 9 : 1 10 1 1 0 0 1
# # # # # # # BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 9 # 1 10 1 1 0 0 1
non-ARDS 110 non-ards n no non non- BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 9 - 1 10 0 0 0 0 1
# # # # # # # BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 9 # 1 10 0 0 0 0 1
# # # # # # # BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 9 # 1 10 0 0 0 0 1
non-ARDS 111 non-ards n no non non- BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 9 - 1 10 0 0 0 0 1
# # # # # # # BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 9 # 1 10 0 0 0 0 1
# # # # # # # BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 9 # 1 10 0 0 0 0 1
0 0 0 0 0 0 0 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 7 9 no 0 1 0 0 0 0 1
20 40 20 2 20 20 20 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 9 no 0 9 0 0 0 0 1
2 0 2 2 2 2 2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 7 9 no 0 10 0 0 0 0 1
2 0 2 2 2 2 2 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 7 9 no 0 9 0 0 0 0 1
0 0 0 0 0 0 0 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 7 9 no 0 10 0 0 0 0 1
200 200 200 2 20 200 200 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 9 no 0 10 0 0 0 0 1
400 400 400 4 40 400 400 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 9 no 0 10 0 0 0 0 1
600 600 600 6 60 600 600 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 9 no 0 10 1 0 0 0 1
CRP (mg/L) crp C CR CRP CRP BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 9 (/) 3 10 0 0 0 0 1
Fig. 4. fig. F Fi Fig Fig. BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 9 ..---, 6 8 0 0 0 0 1
CRP, and crp, C CR CRP CRP, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 9 ,-.()-- 7 9 0 0 0 0 1
and (B and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 9 ()-[()()] 9 8 0 0 0 0 1
and [(C) and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 9 [()()]-.()() 12 9 0 0 0 0 1
biological replicates biological b bi bio biol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 9 [()()]-( 8 9 0 0 0 0 1
replicates are replicates r re rep repl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 9 .),, 4 10 0 0 0 0 1
and [(B) and a an and and BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 9 [()()]- 7 9 0 0 0 0 1
(n = (n ( (n (n (n BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 10 (-, 3 10 0 0 0 0 1
per patient per p pe per per BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 10 ).-. 4 9 0 0 0 0 1
S15. Hash s15. S S1 S15 S15. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 .(#) 4 9 0 0 0 0 1
of detection of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 10 -.() 4 10 0 0 0 0 1
(B) indicate (b) ( (B (B) (B) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 10 ()() 4 9 0 0 0 0 1
(red), whereas (red), ( (r (re (red BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 10 (),()()- 8 9 0 0 0 0 1
detection limits. detection d de det dete BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 10 . 1 2 0 0 0 0 1
RESEARCH | research R RE RES RESE BLOCKSTART PAGEEND NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 1 0 0 0 0 0 7 11 no 0 10 1 1 1 0 0
diluent (80 diluent d di dil dilu BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 () 2 10 0 0 0 0 1
in the in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 7 0 . 1 9 0 0 0 0 1
negative controls negative n ne neg nega BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 . 1 9 0 0 0 0 1
plates were plates p pl pla plat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 no 0 8 0 0 0 0 1
buffer (300 buffer b bu buf buff BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 (), 3 9 0 0 0 0 1
(300 ml), (300 ( (3 (30 (300 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 (), 3 7 0 0 0 0 1
bicarbonate (300 bicarbonate b bi bic bica BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 (). 3 8 0 0 0 0 1
were then were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 no 0 8 0 0 0 0 1
formic acid. formic f fo for form BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 . 1 9 0 0 0 0 1
positive controls, positive p po pos posi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 , 1 8 0 0 0 0 1
eluates from eluates e el elu elua BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 no 0 9 0 0 0 0 1
samples. samples. samples. s sa sam samp BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 . 1 1 0 0 0 0 1
Purification of purification P Pu Pur Puri BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 0 - 1 10 0 0 0 0 1
To isolate to T To To To BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 1 - 1 9 0 0 0 0 1
tients after tients t ti tie tien BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 1 , 1 8 0 0 0 0 1
antigen-coated plates antigen-coated a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 1 -(---,- 7 8 0 0 0 0 1
sorin, Schiphol-Rijk, sorin, s so sor sori BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 1 ,-,) 4 9 0 0 0 0 1
used. Sera used. u us use used BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 1 .() 3 9 0 0 0 0 1
diluent (80 diluent d di dil dilu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 1 () 2 10 0 0 0 0 1
in the in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 7 1 no 0 9 0 0 0 0 1
(RT) with (rt) ( (R (RT (RT) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 1 ().-- 5 7 0 0 0 0 1
resolved samples resolved r re res reso BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 1 ,, 2 8 0 0 0 0 1
the Netherlands the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 1 .- 2 9 0 0 0 0 1
ing and ing i in ing ing BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 7 1 - 1 9 0 0 0 0 1
formed as formed f fo for form BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 1 - 1 8 0 0 0 0 1
antibodies. antibodies. antibodies. a an ant anti BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 1 . 1 2 0 0 0 0 1
Purification of purification P Pu Pur Puri BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 1 - 1 10 1 0 0 0 1
HIV-specific antibodies hiv-specific H HI HIV HIV- BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 2 - 1 10 1 1 0 0 1
antigen-coated plates antigen-coated a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 2 -(..- 5 9 1 1 0 0 1
01, Diasorin, 01, 0 01 01, 01, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 2 ,,-,). 6 9 1 1 0 0 1
Sera were sera S Se Ser Sera BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 2 ()- 3 9 1 1 0 0 1
imen diluent imen i im ime imen BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 2 () 2 8 1 1 0 0 1
incubated in incubated i in inc incu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 2 no 0 8 0 0 0 0 1
temperature (RT) temperature t te tem temp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 2 (). 3 9 0 0 0 0 1
control, anti-HIV control, c co con cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 2 ,- 2 8 0 0 0 0 1
(IgG1 b12; (igg1 ( (I (Ig (IgG BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 2 (; 2 9 0 0 0 0 1
at 1 at a at at at BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 2 /;, 3 8 0 0 0 0 1
Jolla, CA, jolla, J Jo Jol Joll BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 2 ,,). 4 10 0 0 0 0 1
antibodies was antibodies a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 2 no 0 8 0 0 0 0 1
for CMV-specific for f fo for for BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 2 -. 2 5 0 0 0 0 1
Purification of purification P Pu Pur Puri BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 3 - 1 10 0 0 0 0 1
from sera from f fr fro from BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 3 no 0 1 0 0 0 0 1
Parvovirus B19-specific parvovirus P Pa Par Parv BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 3 - 1 10 0 0 0 0 1
using parvovirus using u us usi usin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 3 - 1 8 0 0 0 0 1
(Abcam1788650-Anti-Parvovirus B19 (abcam1788650-anti-parvovirus ( (A (Ab (Abc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 7 3 (-- 3 7 0 0 0 0 1
ELISA, Cambridge, elisa, E EL ELI ELIS BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 3 ,,).() 6 8 0 0 0 0 1
diluted in diluted d di dil dilu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 3 () 2 9 0 0 0 0 1
kit and kit k ki kit kit BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 7 3 no 0 9 0 0 0 0 1
at room at a at at at BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 3 ().- 4 8 0 0 0 0 1
tive and tive t ti tiv tive BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 3 no 0 9 0 0 0 0 1
used as used u us use used BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 3 .- 2 8 0 0 0 0 1
cific antibodies cific c ci cif cifi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 3 no 0 8 0 0 0 0 1
above for above a ab abo abov BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 3 -. 2 7 0 0 0 0 1
Purification of purification P Pu Pur Puri BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 4 -- 2 10 0 0 0 0 1
antibodies from antibodies a an ant anti BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 4 no 0 5 0 0 0 0 1
SARS-Cov-2-specific antibodies sars-cov-2-specific S SA SAR SARS BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 4 --- 3 9 1 0 0 0 1
using antigen-coated using u us usi usin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 4 -(,, 4 9 1 0 0 0 1
Denmark). Plates denmark). D De Den Denm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 4 ). 2 8 1 0 0 0 1
4°C with 4°c 4 4° 4°C 4°C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 4 - 1 8 1 0 0 0 1
tein produced tein t te tei tein BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 4 () 2 9 1 0 0 0 1
N protein n N N N N BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 4 [:, 3 8 1 0 0 0 1
in HEK in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 7 4 - 1 8 1 0 0 0 1
tide, 10x tide, t ti tid tide BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 4 ,,()] 5 10 1 0 0 0 1
(5 mg/ml (5 ( (5 (5 (5 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 4 (//,). 6 9 1 0 0 0 1
were washed were w we wer were BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 () 2 8 1 0 0 0 1
supplemented with supplemented s su sup supp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 .(- 3 7 1 0 0 0 1
T). Plasma t). T T) T). T). BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 4 ).()-() 7 10 1 0 0 0 1
and then and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 - 1 8 1 0 0 0 1
perature (RT) perature p pe per pera BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 4 (). 3 8 1 0 0 0 1
pre COVID-19 pre p pr pre pre BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 4 -- 2 7 1 0 0 0 1
ative controls. ative a at ati ativ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 4 . 1 7 1 0 0 0 1
three times three t th thr thre BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 -(), 4 8 1 0 0 0 1
PBS (250 pbs P PB PBS PBS BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 4 (),- 4 8 1 0 0 0 1
nium bicarbonate nium n ni niu nium BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 4 ().- 4 8 1 0 0 0 1
bodies were bodies b bo bod bodi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 no 0 8 1 0 0 0 1
acid (200 acid a ac aci acid BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 (). 3 3 1 0 0 0 1
Purification of purification P Pu Pur Puri BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 5 no 0 10 1 0 0 0 1
Total IgG1 total T To Tot Tota BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 5 no 0 8 1 0 0 0 1
2 ml 2 2 2 2 2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 8 5 no 0 8 1 0 0 0 1
Fast Flow fast F Fa Fas Fast BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 5 (,, 3 8 1 0 0 0 1
Sweden) in sweden) S Sw Swe Swed BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 5 )-( 3 9 1 0 0 0 1
Multiscreen, Amsterdam, multiscreen, M Mu Mul Mult BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 5 ,,) 3 9 1 0 0 0 1
previously described previously p pr pre prev BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 5 () 2 9 1 0 0 0 1
G cartridges g G G G G BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 8 5 ( 1 9 1 0 0 0 1
Technologies, Santa technologies, T Te Tec Tech BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 5 ,,)., 5 10 1 0 0 0 1
of serum of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 5 no 0 9 1 0 0 0 1
cartridges, followed cartridges, c ca car cart BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 5 , 1 9 1 0 0 0 1
LC-MS pure lc-ms L LC LC- LC-M BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 5 -. 2 9 1 0 0 0 1
eluted with eluted e el elu elut BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 . 1 5 1 0 0 0 1
Mass spectrometric mass M Ma Mas Mass BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 6 - 1 10 0 0 0 0 1
glycosylation analysis glycosylation g gl gly glyc BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 no 0 8 0 0 0 0 1
Eluates containing eluates E El Elu Elua BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 -- 2 9 0 0 0 0 1
bodies or bodies b bo bod bodi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 - 1 8 0 0 0 0 1
plates and plates p pl pla plat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 no 0 7 0 0 0 0 1
for 2.5 for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 ..,,, 5 8 0 0 0 0 1
Parvovirus B19, parvovirus P Pa Par Parv BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ,,- 3 7 0 0 0 0 1
were then were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 no 0 8 0 0 0 0 1
using trypsin using u us usi usin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 (). 3 8 0 0 0 0 1
measles and measles m me mea meas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 no 0 7 0 0 0 0 1
dissolved in dissolved d di dis diss BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 . 1 8 0 0 0 0 1
deoxycholate (SDC), deoxycholate d de deo deox BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 (),, 4 7 0 0 0 0 1
chloroacetamide, and chloroacetamide, c ch chl chlo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 ,.. 3 7 0 0 0 0 1
After a after A Af Aft Afte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 6 -, 2 8 0 0 0 0 1
trypsin in trypsin t tr try tryp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 no 0 7 0 0 0 0 1
was added. was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 . 1 8 0 0 0 0 1
an overnight an a an an an BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 8 6 no 0 8 0 0 0 0 1
formic acid. formic f fo for form BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 .,- 3 8 0 0 0 0 1
cipitates were cipitates c ci cip cipi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 no 0 8 0 0 0 0 1
at 20,000g at a at at at BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 ,.- 3 7 0 0 0 0 1
glycosylation was glycosylation g gl gly glyc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 no 0 7 0 0 0 0 1
reverse phase reverse r re rev reve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 ()-()- 6 8 0 0 0 0 1
an Ultimate an a an an an BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 8 6 (/ 2 7 0 0 0 0 1
Thermo Scientific, thermo T Th The Ther BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ,,) 3 8 0 0 0 0 1
coupled to coupled c co cou coup BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 no 0 7 0 0 0 0 1
(Bruker Daltonics, (bruker ( (B (Br (Bru BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 (,,)- 5 7 0 0 0 0 1
scribed previously scribed s sc scr scri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 ().,, 5 10 0 0 0 0 1
mumps, and mumps, m mu mum mump BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 ,- 2 7 0 0 0 0 1
on an on o on on on BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 --- 3 8 0 0 0 0 1
(Bruker Daltonics) (bruker ( (B (Br (Bru BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 ()(). 5 9 0 0 0 0 1
In the in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 8 6 ,,- 3 8 0 0 0 0 1
out analyzing out o ou out out BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 - 1 9 0 0 0 0 1
ence with ence e en enc ence BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 no 0 8 0 0 0 0 1
level (36). level l le lev leve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 ().- 4 8 0 0 0 0 1
tracted and tracted t tr tra trac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 - 1 8 0 0 0 0 1
ware (version ware w wa war ware BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 8 6 (.;) 4 8 0 0 0 0 1
samples except samples s sa sam samp BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 8 6 ,, 2 8 0 0 0 0 1
Larsen et larsen L La Lar Lars BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 8 9 .,,() 5 10 1 1 0 0 0
26 February 26 2 26 26 26 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 8 9 no 0 3 1 1 0 0 0
7 of 7 7 7 7 7 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 8 9 no 0 10 1 1 0 0 0
A A a A A A A BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 8 9 no 0 10 1 1 0 0 1
B B b B B B B BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 8 9 no 0 10 1 1 0 0 1
C C c C C C C BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 8 9 no 0 10 1 1 0 0 1
Fig. 5. fig. F Fi Fig Fig. BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 9 .. 2 9 1 0 0 0 1
signaling that signaling s si sig sign BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 9 .(): 4 9 1 0 0 0 1
B cell b B B B B BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 8 9 (;), 4 9 1 0 0 0 1
antibodies. (B) antibodies. a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 9 .(),() 6 9 1 0 0 0 1
recognized by recognized r re rec reco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 9 -() 3 9 1 0 0 0 1
provide a provide p pr pro prov BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 9 .() 3 9 1 0 0 0 1
attenuated viruses, attenuated a at att atte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 9 ,- 2 9 1 0 0 0 1
recognition of recognition r re rec reco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 9 (). 3 9 1 0 0 0 1
virus-infected cells virus-infected v vi vir viru BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 9 -/().()() 9 10 1 0 0 0 1
altered glyco-programming altered a al alt alte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 9 -, 2 9 1 0 0 0 1
Fc fucosylation fc F Fc Fc Fc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 9 (,). 4 9 1 0 0 0 1
immune responses immune i im imm immu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 9 ,, 2 9 1 0 0 0 1
different from different d di dif diff BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 9 ()., 4 9 1 0 0 0 1
why immune why w wh why why BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 9 . 1 9 1 0 0 0 1
RESEARCH | research R RE RES RESE BLOCKSTART PAGEEND NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 1 0 0 0 0 0 8 11 no 0 10 1 1 1 0 0
COVID-19 cohorts covid-19 C CO COV COVI BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 - 1 8 1 0 0 0 1
Skyline software skyline S Sk Sky Skyl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 0 (..). 5 10 1 0 0 0 1
judged reliable judged j ju jud judg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 no 0 9 1 0 0 0 1
intensities of intensities i in int inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 ( 1 10 1 0 0 0 1
S3) was s3) S S3 S3) S3) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 ) 1 8 1 0 0 0 1
10 times 10 1 10 10 10 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 8 0 ., 2 9 1 0 0 0 1
the data the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 (). 3 9 1 0 0 0 1
of glycan of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 no 0 9 1 0 0 0 1
in table in i in in in BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 8 0 . 1 2 1 0 0 0 1
Cytokine release cytokine C Cy Cyt Cyto BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 no 0 10 0 0 0 0 1
Monocytes were monocytes M Mo Mon Mono BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 no 0 9 0 0 0 0 1
differentiated as differentiated d di dif diff BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 () 2 10 0 0 0 0 1
M-CSF and m-csf M M- M-C M-CS BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 --. 3 9 0 0 0 0 1
resembling alveolar resembling r re res rese BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 -- 2 9 0 0 0 0 1
derived macrophages derived d de der deri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 (,). 4 8 0 0 0 0 1
IgG immune igg I Ig IgG IgG BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 ,/- 3 7 0 0 0 0 1
engineered IgG1 engineered e en eng engi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 () 2 9 0 0 0 0 1
PBS on pbs P PB PBS PBS BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 --(; 4 8 0 0 0 0 1
Roskilde; Denmark). roskilde; R Ro Ros Rosk BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 ;).(,/ 6 8 0 0 0 0 1
well) were well) w we wel well BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 )- 2 9 0 0 0 0 1
described in described d de des desc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 no 0 8 0 0 0 0 1
20 mg/ml 20 2 20 20 20 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 8 0 /(:)(-).- 9 9 0 0 0 0 1
sure IL-6 sure s su sur sure BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 -,- 3 8 0 0 0 0 1
vested after vested v ve ves vest BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 .- 2 9 0 0 0 0 1
then detected then t th the then BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 -- 2 8 0 0 0 0 1
immunosorbent assay immunosorbent i im imm immu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 () 2 8 0 0 0 0 1
to the to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 '(- 3 9 0 0 0 0 1
Biosciences). coating biosciences). B Bi Bio Bios BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 ). 2 7 0 0 0 0 1
antibodies were antibodies a an ant anti BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 :. 2 6 0 0 0 0 1
Meso Scale meso M Me Mes Meso BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 1 no 0 10 0 0 0 0 1
V-PLEX Custom v-plex V V- V-P V-PL BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 1 -- 2 8 0 0 0 0 1
was purchased was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 1 no 0 8 0 0 0 0 1
(MSD). The (msd). ( (M (MS (MSD BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 1 (). 3 10 0 0 0 0 1
were reconstituted were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 1 no 0 9 0 0 0 0 1
respectively. Plasma respectively. r re res resp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 1 .() 3 8 0 0 0 0 1
diluted in diluted d di dil dilu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 1 - 1 9 0 0 0 0 1
measurement. The measurement. m me mea meas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 1 .- 2 8 0 0 0 0 1
cording to cording c co cor cord BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 1 ' 1 8 0 0 0 0 1
with an with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 1 no 0 9 0 0 0 0 1
samples and samples s sa sam samp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 9 1 .- 2 8 0 0 0 0 1
chemiluminescence signal chemiluminescence c ch che chem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 1 () 2 9 0 0 0 0 1
by MESO by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 1 () 2 9 0 0 0 0 1
and analyzed and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 1 - 1 8 0 0 0 0 1
ware (v4.0, ware w wa war ware BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 9 1 (.,). 5 3 0 0 0 0 1
Anti-SARS-CoV2 antibody anti-sars-cov2 A An Ant Anti BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 1 -- 2 10 0 0 0 0 1
Antibody levels antibody A An Ant Anti BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 1 . 1 9 0 0 0 0 1
Briefly, samples briefly, B Br Bri Brie BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 1 ,-- 3 9 0 0 0 0 1
fold dilutions fold f fo fol fold BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 1 . 1 9 0 0 0 0 1
polysorbate-20 and polysorbate-20 p po pol poly BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 1 -.() 4 8 0 0 0 0 1
microtiter plates microtiter m mi mic micr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 1 - 1 9 0 0 0 0 1
and incubated and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 1 . 1 10 0 0 0 0 1
were produced were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 1 (). 3 9 0 0 0 0 1
After washing, after A Af Aft Afte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 1 ,./- 4 9 0 0 0 0 1
anti-human IgG anti-human a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 1 -(-,) 5 9 0 0 0 0 1
in PTG in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 9 1 .- 2 9 0 0 0 0 1
lowing enzymatic lowing l lo low lowi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 1 , 1 10 0 0 0 0 1
absorbance was absorbance a ab abs abso BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 1 no 0 8 0 0 0 0 1
540 nm. 540 5 54 540 540 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 1 . 1 8 0 0 0 0 1
by comparison by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 1 no 0 8 0 0 0 0 1
of convalescent of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 1 - 1 8 0 0 0 0 1
100 AU/ml. 100 1 10 100 100 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 1 /. 2 2 0 0 0 0 1
Statistical analysis statistical S St Sta Stat BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 2 no 0 10 1 1 0 0 1
Statistical analyses statistical S St Sta Stat BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 2 no 0 8 1 0 0 0 1
GraphPad Prism graphpad G Gr Gra Grap BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 2 (..) 4 8 1 0 0 0 1
(GraphPad Software, (graphpad ( (G (Gr (Gra BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 2 (,,;. 5 7 1 0 0 0 1
graphpad.com). To graphpad.com). g gr gra grap BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 2 .).- 4 7 1 0 0 0 1
fucosylation for fucosylation f fu fuc fuco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 2 - 1 8 1 0 0 0 1
IgG differs igg I Ig IgG IgG BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 2 ,- 2 9 1 0 0 0 1
tical analysis tical t ti tic tica BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 2 - 1 8 1 0 0 0 1
analysis of analysis a an ana anal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 2 () 2 8 1 0 0 0 1
t tests t t t t t BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 9 2 . 1 10 1 0 0 0 1
The same the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 2 - 1 8 1 0 0 0 1
kine release kine k ki kin kine BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 2 . 1 8 1 0 0 0 1
To investigate to T To To To BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 2 -- 2 8 1 0 0 0 1
files of files f fi fil file BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 2 no 0 9 1 0 0 0 1
individual were individual i in ind indi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 2 , 1 10 1 0 0 0 1
was performed was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 2 '. 2 9 1 0 0 0 1
A Pearson's a A A A A BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 9 2 ' 1 9 1 0 0 0 1
the correlation the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 2 - 1 8 1 0 0 0 1
anti-S and anti-s a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 2 --.- 4 9 1 0 0 0 1
tween cytokine tween t tw twe twee BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 2 -, 2 9 1 0 0 0 1
as well as a as as as BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 2 - 1 8 1 0 0 0 1
fucosylation and fucosylation f fu fuc fuco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 2 ,' 2 8 1 0 0 0 1
correlation was correlation c co cor corr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 2 .- 2 8 1 0 0 0 1
cally significant cally c ca cal call BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 9 2 ;* 2 9 1 0 0 0 1
0.05, **P 0.05, 0 0. 0.0 0.05 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 2 .,**.,***.,****.. 17 9 1 0 0 0 1
REFERENCES AND references R RE REF REFE BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 9 3 no 0 10 0 0 0 0 1
1. M. 1. 1 1. 1. 1. BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 .....,- 7 8 0 0 0 0 1
immunoglobulin G immunoglobulin i im imm immu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 3 no 0 7 0 0 0 0 1
inflammation. Lupus inflammation. i in inf infl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 3 .,-().:./ 9 7 0 0 0 0 1
0961203316640368; pmid: 0961203316640368; 0 09 096 0961 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 3 ;: 2 4 0 0 0 0 1
2. R. 2. 2 2. 2. 2. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 ..,- 4 9 0 0 0 0 1
based therapeutics. based b ba bas base BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 3 ....,-(). 9 9 0 0 0 0 1
doi: 10.1038/nrd2804; doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 3 :./;: 5 5 0 0 0 0 1
3. G. 3. 3 3. 3. 3. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 ..,.,., 7 8 0 0 0 0 1
allotypes: From allotypes: a al all allo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 3 :... 4 9 0 0 0 0 1
5, 520 5, 5 5, 5, 5, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 ,().:./..; 10 6 0 0 0 0 1
pmid: 25368619 pmid: p pm pmi pmid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 3 : 1 2 0 0 0 0 1
4. G. 4. 4 4. 4. 4. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 ..,.,., 7 9 0 0 0 0 1
immunoglobulin G immunoglobulin i im imm immu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 3 . 1 8 0 0 0 0 1
Front. Immunol. front. F Fr Fro Fron BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 3 ..,().:./ 9 6 0 0 0 0 1
fimmu.2018.00553; pmid: fimmu.2018.00553; f fi fim fimm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 3 ..;: 4 4 0 0 0 0 1
5. R. 5. 5 5. 5. 5. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 ....,- 6 9 0 0 0 0 1
oligosaccharide improves oligosaccharide o ol oli olig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 3 no 0 8 0 0 0 0 1
antibody-dependent cellular antibody-dependent a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 3 -...., 6 8 0 0 0 0 1
26733-26740 (2002). 26733-26740 2 26 267 2673 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 3 -().:./.; 9 7 0 0 0 0 1
pmid: 11986321 pmid: p pm pmi pmid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 3 : 1 2 0 0 0 0 1
6. C. 6. 6 6. 6. 6. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 ...,- 5 8 0 0 0 0 1
interactions are interactions i in int inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 3 no 0 8 0 0 0 0 1
FcgRIII and fcgriii F Fc Fcg FcgR BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 3 .... 4 9 0 0 0 0 1
Sci. U.S.A. sci. S Sc Sci Sci. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 3 ....,-().:./ 12 7 0 0 0 0 1
pnas.1108455108; pmid: pnas.1108455108; p pn pna pnas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 3 .;: 3 4 0 0 0 0 1
7. J. 7. 7 7. 7. 7. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 ...,.,- 7 9 0 0 0 0 1
(2016). doi: (2016). ( (2 (20 (201 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 3 ().:./..;: 10 8 0 0 0 0 1
8. M. 8. 8 8. 8. 8. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 ....,-- 7 9 0 0 0 0 1
profiling by profiling p pr pro prof BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 3 .. 2 8 0 0 0 0 1
Res. 12, res. R Re Res Res. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 3 .,-().:./; 10 7 0 0 0 0 1
pmid: 23298168 pmid: p pm pmi pmid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 3 : 1 2 0 0 0 0 1
9. N. 9. 9 9. 9. 9. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 ..,..,.,., 10 8 0 0 0 0 1
M. Wuhrer, m. M M. M. M. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 3 .,- 3 8 0 0 0 0 1
after birth after a af aft afte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 3 ..., 4 8 0 0 0 0 1
1853-1861 (2016). 1853-1861 1 18 185 1853 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 3 -().:./..; 10 7 0 0 0 0 1
pmid: 27161864 pmid: p pm pmi pmid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 3 : 1 2 0 0 0 0 1
10. X. 10. 1 10 10. 10. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 ...,- 5 10 0 0 0 0 1
chronological and chronological c ch chr chro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 3 :- 2 9 0 0 0 0 1
a Han a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 9 3 .(), 4 8 0 0 0 0 1
(2016). doi: (2016). ( (2 (20 (201 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 3 ().:./.; 8 6 0 0 0 0 1
pmid: 27428197 pmid: p pm pmi pmid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 3 : 1 2 0 0 0 0 1
11. M. 11. 1 11 11. 11. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 ..., 4 9 0 0 0 0 1
during alloimmune during d du dur duri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 3 . 1 8 0 0 0 0 1
J. Proteome j. J J. J. J. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 3 ..,-().:./; 11 8 0 0 0 0 1
pmid: 18942870 pmid: p pm pmi pmid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 3 : 1 2 0 0 0 0 1
12. R. 12. 1 12 12. 12. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 ...,- 5 9 0 0 0 0 1
platelet alloantibodies platelet p pl pla plat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 3 .,- 3 8 0 0 0 0 1
(2014). doi: (2014). ( (2 (20 (201 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 3 ().:./---;: 11 8 0 0 0 0 1
13. R. 13. 1 13 13. 13. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 6 ...,---: 8 9 1 0 0 0 1
A new a A A A A BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 9 6 no 0 8 1 0 0 0 1
fetus and fetus f fe fet fetu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 ....,-(). 9 7 1 0 0 0 1
doi: 10.1111/bjh.12965; doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 6 :./.;: 6 5 1 0 0 0 1
14. M. 14. 1 14 14. 14. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 6 ....,- 6 9 1 0 0 0 1
is stable is i is is is BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 no 0 8 1 0 0 0 1
alloimmune thrombocytopenia. alloimmune a al all allo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 6 ....,- 6 7 1 0 0 0 1
(2016). doi: (2016). ( (2 (20 (201 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 6 ().:./.;: 9 6 1 0 0 0 1
15. T. 15. 1 15 15. 15. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 6 ...., 5 8 1 0 0 0 1
FcgRIIIA binding fcgriiia F Fc Fcg FcgR BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 6 ., 2 7 1 0 0 0 1
395-398 (2017). 395-398 3 39 395 395- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 6 -().:./.;: 10 8 1 0 0 0 1
16. M. 16. 1 16 16. 16. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 6 ...., 5 9 1 0 0 0 1
HIV-specific antibodies hiv-specific H HI HIV HIV- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 6 -...., 6 10 1 0 0 0 1
2183-2192 (2013). 2183-2192 2 21 218 2183 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 6 -().:./;: 9 7 1 0 0 0 1
17. M. 17. 1 17 17. 17. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 6 ....,- 6 9 1 0 0 0 1
blood cell blood b bl blo bloo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 - 1 7 1 0 0 0 1
severity of severity s se sev seve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 ... 3 8 1 0 0 0 1
Haematol. 176, haematol. H Ha Hae Haem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 6 .,-().:./.; 11 7 1 0 0 0 1
pmid: 27891581 pmid: p pm pmi pmid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 6 : 1 2 1 0 0 0 1
18. M. 18. 1 18 18. 18. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 6 .....,- 7 8 1 0 0 0 1
N-glycosylation upon n-glycosylation N N- N-g N-gl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 6 -.. 3 8 1 0 0 0 1
Cell. Proteomics cell. C Ce Cel Cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 6 .,().:./. 9 7 1 0 0 0 1
M111.014563; pmid: m111.014563; M M1 M11 M111 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 6 .;: 3 3 1 0 0 0 1
19. J. 19. 1 19 19. 19. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 6 ..., 4 9 1 0 0 0 1
and biological and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 ......., 8 8 1 0 0 0 1
779-789 (2014). 779-789 7 77 779 779- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 6 -().:.//;: 10 7 1 0 0 0 1
20. L. 20. 2 20 20. 20. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 6 ..,..,..,., 11 8 1 0 0 0 1
J. F. j. J J. J. J. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 6 ..,--: 6 7 1 0 0 0 1
considerations and considerations c co con cons BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 . 1 7 1 0 0 0 1
Intensive Care intensive I In Int Inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 6 .,-().:./ 9 7 1 0 0 0 1
s00134-020-05967-x; pmid: s00134-020-05967-x; s s0 s00 s001 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 6 ---;: 5 4 1 0 0 0 1
21. C. 21. 2 21 21. 21. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 6 ..., 4 9 1 0 0 0 1
novel coronavirus novel n no nov nove BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 ,.,- 4 7 1 0 0 0 1
(2020). doi: (2020). ( (2 (20 (202 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 6 ().:./-()-; 11 5 1 0 0 0 1
pmid: 31986264 pmid: p pm pmi pmid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 6 : 1 2 1 0 0 0 1
22. C. 22. 2 22 22. 22. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 6 ..,..,- 7 8 1 0 0 0 1
coronavirus. J. coronavirus. c co cor coro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 6 ....,-().:./ 12 8 1 0 0 0 1
jmv.25700; pmid: jmv.25700; j jm jmv jmv. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 6 .;: 3 3 1 0 0 0 1
23. T. 23. 2 23 23. 23. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 6 ....,- 6 8 1 0 0 0 1
Selection and selection S Se Sel Sele BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 6 ., 2 8 1 0 0 0 1
160-169 (2015). 160-169 1 16 160 160- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 6 -().:./....; 12 6 1 0 0 0 1
pmid: 26140596 pmid: p pm pmi pmid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 6 : 1 2 1 0 0 0 1
24. G. 24. 2 24 24. 24. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 6 ..., 4 7 1 0 0 0 1
G-glycan repertoire g-glycan G G- G-g G-gl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 6 --- 3 7 1 0 0 0 1
complement-mediated-effector activities. complement-mediated-effector c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 6 --..., 6 8 1 0 0 0 1
877 (2017). 877 8 87 877 877 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 6 ().:./..;: 10 7 1 0 0 0 1
25. A. 25. 2 25 25. 25. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 6 ....,, 6 8 1 0 0 0 1
effector cells, effector e ef eff effe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 6 ,- 2 8 1 0 0 0 1
antibody-dependent cellular antibody-dependent a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 6 -..., 5 7 1 0 0 0 1
3126-3135 (2019). 3126-3135 3 31 312 3126 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 6 -().:./.; 9 6 1 0 0 0 1
pmid: 31748349 pmid: p pm pmi pmid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 6 : 1 2 1 0 0 0 1
26. E. 26. 2 26 26. 26. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 6 ....,-- 7 8 1 0 0 0 1
antibody assay antibody a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 6 no 0 7 1 0 0 0 1
time in time t ti tim time BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 no 0 7 1 0 0 0 1
COVID-19. J. covid-19. C CO COV COVI BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 6 -...,-().:./ 12 7 1 0 0 0 1
jimmunol.2000767; pmid: jimmunol.2000767; j ji jim jimm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 6 .;: 3 4 1 0 0 0 1
27. R. 27. 2 27 27. 27. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 6 ...,- 5 8 1 0 0 0 1
variable decreases variable v va var vari BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 --., 4 8 1 0 0 0 1
553-562 (2015). 553-562 5 55 553 553- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 6 -().:./.;: 10 7 1 0 0 0 1
28. N. 28. 2 28 28. 28. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 6 ...,.,., 8 9 1 0 0 0 1
serological memory serological s se ser sero BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 6 no 0 8 1 0 0 0 1
B cells. b B B B B BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 9 6 .,-().:./ 9 7 1 0 0 0 1
science.1076071; pmid: science.1076071; s sc sci scie BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 6 .;: 3 4 1 0 0 0 1
29. M. 29. 2 29 29. 29. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 6 .....,- 7 9 1 0 0 0 1
phase responses. phase p ph pha phas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 .,().:./- 9 7 1 0 0 0 1
6736(87)91413-9; pmid: 6736(87)91413-9; 6 67 673 6736 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 6 ()-;: 5 4 1 0 0 0 1
30. A. 30. 3 30 30. 30. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 6 ..,.,:, 7 8 1 0 0 0 1
Value in value V Va Val Valu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 6 , 1 8 1 0 0 0 1
development. Adv. development. d de dev deve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 ...,-().:./ 11 8 1 0 0 0 1
bs.aivir.2016.07.001; pmid: bs.aivir.2016.07.001; b bs bs. bs.a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 6 ....;: 6 5 1 0 0 0 1
31. L. 31. 3 31 31. 31. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 6 ...,- 5 9 1 0 0 0 1
skewing macrophage skewing s sk ske skew BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 6 - 1 6 1 0 0 0 1
infection. JCI infection. i in inf infe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 .,().:./. 9 8 1 0 0 0 1
insight.123158; pmid: insight.123158; i in ins insi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 6 .;: 3 4 1 0 0 0 1
32. B. 32. 3 32 32. 32. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 6 ..,.,.,.,.,., 13 7 1 0 0 0 1
M. Parcells, m. M M. M. M. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 6 .,.,.,.,.,., 12 7 1 0 0 0 1
bioRxiv 036418 biorxiv b bi bio bioR BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 6 []...:./ 8 7 1 0 0 0 1
2020.04.10.036418 2020.04.10.036418 2020.04.10.036418 2 20 202 2020 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 6 ... 3 2 1 0 0 0 1
33. Q. 33. 3 33 33. 33. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 6 ..,.,., 7 8 1 0 0 0 1
'Cytokine Storm' 'cytokine ' 'C 'Cy 'Cyt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 6 ''-...,-(). 11 8 1 0 0 0 1
doi: 10.1016/j.jinf.2020.03.037; doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 6 :./....;: 9 6 1 0 0 0 1
34. P. 34. 3 34 34. 34. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 6 ....., 6 8 1 0 0 0 1
COVID-19 patients covid-19 C CO COV COVI BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 6 -. 2 8 1 0 0 0 1
Larsen et larsen L La Lar Lars BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 10 11 .,,() 5 10 1 1 0 0 0
26 February 26 2 26 26 26 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 10 11 no 0 3 1 1 0 0 0
8 of 8 8 8 8 8 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 10 11 no 0 10 1 1 0 0 0
RESEARCH | research R RE RES RESE BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 1 0 0 0 0 0 10 11 no 0 10 1 1 1 0 0
Science 369, science S Sc Sci Scie BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 0 ,-().:./.; 10 8 1 0 0 0 1
pmid: 32540902 pmid: p pm pmi pmid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 : 1 2 1 0 0 0 1
35. D. 35. 3 35 35. 35. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 ..,..,.,.,- 11 10 1 0 0 0 1
analysis of analysis a an ana anal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 -... 4 9 1 0 0 0 1
1503, 31-47 1503, 1 15 150 1503 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 0 ,-().:./----; 13 8 1 0 0 0 1
pmid: 27743357 pmid: p pm pmi pmid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 : 1 2 1 0 0 0 1
36. M. 36. 3 36 36. 36. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 ..., 4 9 1 0 0 0 1
(IgG) subclasses (igg) ( (I (Ig (IgG BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 ()., 4 7 1 0 0 0 1
4070-4081 (2007). 4070-4081 4 40 407 4070 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 -().:./.; 9 7 1 0 0 0 1
pmid: 17994628 pmid: p pm pmi pmid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 : 1 2 1 0 0 0 1
37. W. 37. 3 37 37. 37. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 ..,.-.,.,.,., 13 9 1 0 0 0 1
A. U. a. A A. A. A. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 10 0 ...-,.,.,., 11 8 1 0 0 0 1
T. Caniels, t. T T. T. T. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 .,.,.,., 8 8 1 0 0 0 1
R. Jonkers, r. R R. R. R. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 .,.,.,.,., 10 7 1 0 0 0 1
F. van f. F F. F. F. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 .,.,.,.,., 10 9 1 0 0 0 1
L. Willemsen, l. L L. L. L. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 .,.,..,., 9 7 1 0 0 0 1
G. Vidarsson, g. G G. G. G. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 .,.,.,--- 9 8 1 0 0 0 1
IgG from igg I Ig IgG IgG BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 - 1 8 1 0 0 0 1
hyper-inflammatory responses. hyper-inflammatory h hy hyp hype BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 -.[] 4 8 1 0 0 0 1
13 July 13 1 13 13 13 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 10 0 ..:./... 8 6 1 0 0 0 1
38. H. 38. 3 38 38. 38. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 ....,-- 7 9 1 0 0 0 1
macrophages identifies macrophages m ma mac macr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 no 0 8 1 0 0 0 1
classify disease classify c cl cla clas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 ... 3 8 1 0 0 0 1
10, 2887 10, 1 10 10, 10, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 ,().:./..; 10 7 1 0 0 0 1
pmid: 31921150 pmid: p pm pmi pmid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 : 1 2 1 0 0 0 1
39. G. 39. 3 39 39. 39. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 ...,-- 6 10 1 0 0 0 1
generate IgG generate g ge gen gene BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 -..., 5 8 1 0 0 0 1
(2016). doi: (2016). ( (2 (20 (201 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 0 ().:./;: 8 7 1 0 0 0 1
ACKNOWLEDGMENTS ACKNOWLEDGMENTS acknowledgments A AC ACK ACKN BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 11 3 no 0 10 1 1 0 0 1
We thank we W We We We BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 3 .... 4 7 1 0 0 0 1
Amsterdam Cohort amsterdam A Am Ams Amst BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 3 no 0 7 1 0 0 0 1
collaboration between collaboration c co col coll BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 3 , 1 7 1 0 0 0 1
Academic Medical academic A Ac Aca Acad BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 3 , 1 7 1 0 0 0 1
Sanquin Blood sanquin S Sa San Sanq BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 3 . 1 7 1 0 0 0 1
Netherlands HIV netherlands N Ne Net Neth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 3 no 0 7 1 0 0 0 1
supported by supported s su sup supp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 3 no 0 8 1 0 0 0 1
and the and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 3 . 1 7 1 0 0 0 1
participants for participants p pa par part BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 3 .: 2 8 1 0 0 0 1
was supported was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 3 (..), 5 7 1 0 0 0 1
European Union european E Eu Eur Euro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 3 ( 1 6 1 0 0 0 1
project, grant project, p pr pro proj BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 3 ,,,), 5 8 1 0 0 0 1
Marie Skłodowska-Curie marie M Ma Mar Mari BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 11 3 -(...), 7 8 1 0 0 0 1
Organization for organization O Or Org Orga BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 11 3 ()(...), 8 8 1 0 0 0 1
ZonMW COVID-19 zonmw Z Zo Zon ZonM BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 3 -(...) 6 7 1 0 0 0 1
01 201 01 0 01 01 01 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 11 3 (..),-(...) 11 7 1 0 0 0 1
and 24175 and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 3 (....) 6 7 1 0 0 0 1
Immunity Institute. immunity I Im Imm Immu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 3 .: 2 7 1 0 0 0 1
collected by collected c co col coll BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 3 ..,..,....,....,..,...,..,..,..., 33 10 1 0 0 0 1
F.L., N.A.K., f.l., F F. F.L F.L. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 3 ..,...,...,..,...;...,....,...,.., 34 9 1 0 0 0 1
M.D.L., and m.d.l., M M. M.D M.D. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 3 ...,...., 9 7 1 0 0 0 1
spectrometric analyses, spectrometric s sp spe spec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 3 ,...,..,.., 11 8 1 0 0 0 1
P.J.M.B. generated p.j.m.b. P P. P.J P.J. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 3 .........- 10 8 1 0 0 0 1
COVID-19 ELISAs. covid-19 C CO COV COVI BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 3 -....,...,...,...,....,.., 26 8 1 0 0 0 1
C.E.v.d.S. analyzed c.e.v.d.s. C C. C.E C.E. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 3 ........ 8 9 1 0 0 0 1
C.E.G. performed c.e.g. C C. C.E C.E. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 3 ... 3 8 1 0 0 0 1
ELISAs. H.-J.C. elisas. E EL ELI ELIS BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 3 ..-......,..., 14 9 1 0 0 0 1
E.L.d.G., M.W., e.l.d.g., E E. E.L E.L. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 8 ....,..,.......,..., 20 9 1 0 0 0 1
J.d.D., T.R., j.d.d., J J. J.d J.d. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 8 ...,..,...,.....,..,... 23 10 1 0 0 0 1
authors contributed authors a au aut auth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 8 ...., 5 9 1 0 0 0 1
M.E.S., E.L.d.G., m.e.s., M M. M.E M.E. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 8 ...,....,.....,..,.., 21 9 1 0 0 0 1
critically revised critically c cr cri crit BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 8 .: 2 9 1 0 0 0 1
The authors the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 8 . 1 8 1 0 0 0 1
availability: All availability: a av ava avai BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 8 : 1 9 1 0 0 0 1
materials. This materials. m ma mat mate BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 8 . 1 9 1 0 0 0 1
4.0 International 4.0 4 4. 4.0 4.0 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 8 .(.),, 6 9 1 0 0 0 1
distribution, and distribution, d di dis dist BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 8 ,, 2 9 1 0 0 0 1
work is work w wo wor work BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 8 .,:// 5 9 1 0 0 0 1
creativecommons.org/licenses/by/4.0/. This creativecommons.org/licenses/by/4.0/. c cr cre crea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 8 .///./. 7 8 1 0 0 0 1
to figures/photos/artwork to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 8 // 2 9 1 0 0 0 1
is credited is i is is is BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 8 ; 1 9 1 0 0 0 1
before using before b be bef befo BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 8 . 1 3 1 0 0 0 1
SUPPLEMENTARY MATERIALS supplementary S SU SUP SUPP BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 11 11 no 0 10 0 0 0 0 1
science.sciencemag.org/content/371/6532/eabc8378/suppl/DC1 science.sciencemag.org/content/371/6532/eabc8378/suppl/DC1 science.sciencemag.org/content/371/6532/eabc8378/suppl/dc1 s sc sci scie BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 11 ..////// 8 10 0 0 0 0 1
Figs. S1 figs. F Fi Fig Figs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 11 . 1 2 0 0 0 0 1
Tables S1 tables T Ta Tab Tabl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 11 11 no 0 2 0 0 0 0 1
Amsterdam UMC amsterdam A Am Ams Amst BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 11 - 1 7 0 0 0 0 1
MDAR Reproducibility mdar M MD MDA MDAR BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 11 no 0 5 0 0 0 0 1
View/request a view/request V Vi Vie View BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 11 /-. 3 10 0 0 0 0 1
16 May 16 1 16 16 16 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 11 11 ; 1 10 0 0 0 0 1
Published online published P Pu Pub Publ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 11 no 0 8 0 0 0 0 1
10.1126/science.abc8378 10.1126/science.abc8378 10.1126/science.abc8378 1 10 10. 10.1 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 11 ./. 3 6 0 0 0 0 1
Larsen et larsen L La Lar Lars BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 11 11 .,,() 5 10 1 1 0 0 0
26 February 26 2 26 26 26 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 11 11 no 0 3 1 1 0 0 0
9 of 9 9 9 9 9 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 11 11 no 0 10 1 1 0 0 0
RESEARCH | research R RE RES RESE BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 1 0 0 0 0 0 11 11 no 0 10 1 1 1 0 0

